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Salmonella causes disease ranging from self-limiting enteritis to 
septicemia.  To cause disease it must first invade the intestinal epithelium.  To 
invade, it employs a type three secretion system and effector proteins 
encoded on Salmonella Pathogenicity Island 1 (SPI 1).  In this work, we 
investigated the effects of the intestinal environment on Salmonella 
pathogenesis using an in vivo mouse model of infection as well as in vitro 
genetic studies.   
In our in vivo studies, we characterized the intestinal environment in 
control, streptomycin-treated, Salmonella infected, and streptomycin-treated, 
Salmonella infected mice.  Using 16S rDNA clone libraries we found that the 
microbiota in the ileum is different from that of the cecum and that 
streptomycin treatment alters the microbiota in both the ileum and cecum.  
Upon histopathological examination of the ileum, we also found that 
pretreatment with streptomycin prior to infection increased Salmonella 
pathology.  We also defined the short chain fatty acids present in both the 
ileum and cecum using GC-MS and HPLC analysis and found that 
streptomycin treatment significantly decreased the fatty acid concentrations in 
the cecum and that this change correlated with an increase in pathology in the 
cecum.   
Previous in vitro studies in our lab have shown that the short chain fatty 
acids propionate and butyrate repress Salmonella SPI 1 invasion genes.  In 
this work, we further confirmed the effects of propionate and butyrate using 
concentrations of the fatty acids comparable to what we found in the cecum of 
the mouse.  We also found that metabolism of propionate is necessary for the 
repressive effect on invasion genes and that the metabolic intermediate, 
propionyl-CoA, is important for this effect. 
The molecular techniques used to define the microbiota of the intestinal 
environment are also applicable to the clinical laboratory setting.  Use of 
ribosomal genes for species-level identification has shown promise for both 
bacteria and yeast.  Therefore, we examined the usefulness of these 
techniques for yeast identification in the clinical veterinary laboratory and 
found that sequence analysis of the D1/D2 region of the yeast large ribosomal 
subunit is an effective method of identification. 
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CHAPTER 1 
INTRODUCTION 
   
2 
Salmonella significance for public health 
 Salmonella enterica is a Gram negative bacterium that is a major cause 
of food-borne illness.  It can cause disease with varying levels of severity 
causing a range of illnesses from self-limiting intestinal disease to septicemia.  
The majority of cases are resolved without treatment; however, more severe 
cases can occur, most commonly in infants, elderly populations, or people who 
are immunocompromised.  Because most cases are resolved without 
treatment, it is difficult to quantify the number of cases that occur each year; 
however, the Centers for Disease Control and Prevention (CDC) estimate an 
incidence of 1.4 million cases per year resulting in approximately 400 deaths 
(1).   Salmonella transmission usually occurs by eating contaminated food, 
and it is difficult to control transmission because it is commonly found in food 
animals such as chickens, cows, and pigs, along with contaminated produce.   
   It has now been determined that there are only two species of 
Salmonella, and Salmonella enterica is the more important of these, causing 
99% of infections in humans and warm-blooded animals (13).  However, in the 
species enterica there are over 2,400 named serotypes (13).  Of these over 
2,400 serotypes, six account for 61% of human infections, with serovars 
Typhimurium and Enteritidis accounting for almost 40% (15).  Furthermore, of 
the enteric pathogens under surveillance in 2005, Salmonella had the highest 
incidence with an overall incidence of 14.55 per 100,000 people (15).  
Therefore, Salmonella enterica serovar Typhimurium (henceforth referred to 
as Salmonella Typhimurium) is a significant human pathogen. 
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Salmonella invasion of the intestinal tract 
In order for Salmonella to cause disease, it must first penetrate the 
intestinal epithelium.  For this invasion process, Salmonella uses genes found 
in Salmonella pathogenicity island 1 (SPI 1), an island of genes located at 
centisome 63 in S. Typhimurium  (11, 32, 34, 41, 52, 58, 64).  These genes 
encode structural components of a type three secretion system and its effector 
proteins.  The type three secretion system apparatus is encoded by the 
inv/spa operon and the prg/org operon, whereas the secreted effectors within 
the island are encoded in the sic/sip operon (reviewed by 2).  The process of 
invasion involves this TTSS forming a ―needle complex‖ (44) that  delivers 
these effector proteins into the host cell cytoplasm, causing a change in the 
cytoskeleton of the host cell, leading to engulfment of the bacterium (reviewed 
by 31).  It has been demonstrated that SPI 1 genes are required for both 
intestinal disease and systemic disease in mice (10, 32, 41, 73). 
  
SPI 1 gene regulation 
SPI 1 genes are controlled by a complex regulatory network of 
transcriptional and post-transcriptional regulators.  Many of these regulators 
are located within SPI 1, however, it is thought that SPI 1 was obtained by 
horizontal transfer at some point in evolution (2, 31), so after its acquisition it 
came under the control of regulators outside the island as well.  Regulators 
within the island are HilA, HilC, HilD, and InvF, with HilA characterized as the 
central regulator.  HilA, a member of the OmpR/ToxR family, is a 
transcriptional activator that regulates transcription of the following genes in 
SPI 1:  the inv/spa operons, the prg/org operons, and the sic/sip operon via 
the read-through transcript of the inv/spa operons (7, 20, 55).  InvF is also a 
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transcriptional regulator of the AraC family (43).  HilA is responsible for 
controlling gene expression of the TTSS apparatus, InvF is responsible for 
controlling secreted effectors outside of SPI 1, and together they control 
secreted effectors within SPI 1 (20, 26).  InvF can be regulated by 
mechanisms independent of HilA, as well (3, 4, 62).  HilA is controlled by HilC 
and HilD from within the island and RtsA and HilE outside SPI 1(27).  Also, a 
recent study has shown that by an unknown mechanism, HilA can negatively 
regulate itself (22).   
Several genes encoded outside of SPI 1 have been identified as 
important for control of HilA and InvF.  Some examples include PhoP/PhoQ, 
BarA/SirA, and the Csr system.  PhoP/PhoQ has been shown to negatively 
regulate invasion genes through HilA (8).  This negative regulation is induced 
by low magnesium concentrations (68).  The csr system both positively and 
negatively regulates SPI 1 invasion gene expression through changes in the 
level of CsrA (3).  In Salmonella it consists of a small protein CsrA, and two 
untranslated RNAs, CsrB and CsrC, that control the level of CsrA (3, 29).  The 
BarA/SirA regulatory system positively regulates invasion gene expression.  
BarA is a sensor kinase of the phosphorelay type, and SirA is its response 
regulator (4, 70).  BarA/SirA induce invasion gene expression through their 
effect on expression of CsrB and CsrC (29, 49).  It is thought that BarA/SirA 
induce expression of CsrB and CsrC, decreasing the levels of free CsrA ,and 
inducing invasion gene expression (2). 
 
Environmental control of invasion genes 
 Environmental factors mediate invasion gene expression through 
regulation of hilA expression (8).  The conditions that positively regulate SPI 1 
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gene expression are  low oxygen, log phase growth, high osmolarity, changes 
in DNA supercoiling, and slightly alkaline pH (8, 28, 33, 51, 65).  Results from 
our lab also show that short chain fatty acid concentrations and pH are 
important for invasion gene expression.  Acetate and formate induce invasion 
gene expression, whereas butyrate and propionate repress invasion gene 
expression and these short chain fatty acids are more effective at a pH of 6.7 
rather than 8.0 (36, 49).   
 
The intestinal environment 
 Studies have been done to better understand the intestinal 
environment, and many of the environmental conditions listed above can be 
found in the intestinal tract.  There exists an axial oxygen gradient in the gut, 
with the lumen of the small intestine and colon being anaerobic, whereas the 
mucosal surface is microaerobic (21).  The osmolality of the small intestine in 
humans is 250-425 mOsmol/kg depending on the location within the small 
intestine and the state of digestion (40, 46).  Additionally, in various 
mammalian species, studies show that acetate, propionate, and butyrate are 
found in both the cecum and the colon, and that acetate, propionate, and 
formate have been found in the ileum (5, 12, 19, 47, 48, 57).  Also, the pH 
throughout the distal ileum, cecum, and proximal colon is between 6.0 and 7.0 
(6, 12).  As there are differences in the fatty acids concentrations in the ileum 
and the large intestine, it seems likely that these conditions in the intestinal 
tract are signals for Salmonella, indicating a location for productive invasion.  
The conditions in the ileum, the area previously described as the location for 
invasion (14, 42), are conditions known to induce invasion genes (36, 49), 
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whereas the conditions of the cecum and colon may be more likely to repress 
invasion genes (49).   
 
Microbiota of the intestinal tract 
 To understand the intestinal environment, it is important to consider the 
microbiota present there, as well.  There are 1012 microbes/gram of contents 
in the distal intestinal tract, and it is estimated that there are 500-1,000 
different species present (23, 75).  However, of these species present, the 
majority belong to two phyla, either the Firmicutes or Bacteroidetes, and this is 
true for both mice and humans (25, 53).  Understanding the components of the 
microbiota present is important, because protection from enteric pathogens 
has been attributed to the intestinal microbiota and termed ―colonization 
resistance‖ (72).  Also, the short chain fatty acids present in the intestinal tract 
are there because of bacterial fermentation of undigested carbohydrates such 
as pectins, cellulose, and hemicelluloses (19).  Therefore, it is important to 
characterize the intestinal environment to better understand how the 
microbiota and their metabolic products interact with enteric pathogens, in 
particular Salmonella.  Many studies have been performed to characterize the 
microbiota present in the large intestine (the cecum, colon, and feces) of both 
mice and humans (24, 25, 37, 45, 53, 67, 69, 71).  In contrast with the wealth 
of information now available regarding the composition of the large intestinal 
microbiota, relatively little is known about that of the mouse small intestine.   A 
comprehensive survey of the microbiota in the human small intestine has been 
completed with predominating groups consisting of the Firmicutes 
(Lachnospiraceae and Bacillus) and the Bacteroidetes (30).  However, studies 
in mice have been more limited in their scope (9, 38, 63). 
   
7 
16S rDNA analysis  
The majority of the studies characterizing the intestinal microbiota 
employed 16S rDNA analysis of genomic DNA isolated from the tissue or 
contents in this region of the intestinal tract.  16S rDNA analysis is useful 
because the 16S rDNA gene in bacteria has highly conserved regions with 
hypervariable regions in between (56, 66).  The regions of high conservation 
among bacterial species allow for design of universal primers that will amplify 
the majority of bacterial species, whereas the hypervariable regions in 
between allow for identification of bacteria to the genus or species level (66).  
Therefore, 16S rDNA analysis provides a unique tool for characterization of 
bacterial populations.  
 
16S rDNA sequence analysis in the clinical microbiology laboratory 
16S rDNA sequence analysis can also be employed for bacterial 
identification in a clinical microbiology setting.  Traditionally phenotypic 
methods have been utilized for bacterial identification in the clinical laboratory, 
however, recent studies of 16S rDNA analysis have shown success with 
implementation of 16S rDNA sequence analysis for identification of bacteria in 
the clinical laboratory setting (reviewed by 74).  The method involves isolating 
bacterial DNA from a bacterial colony or a clinical sample and then amplifying 
the 16S rRNA gene using PCR.  The PCR product is then sequenced and the 
sequence is identified using one of the various public or commercial sequence 
databases.  This method is particularly advantageous for identification of 
unusual isolates, isolates with limited biochemical reactivity, and for isolates 
that do not grow well under in vitro conditions.   
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Sequence analysis of yeast in the clinical laboratory 
In addition to molecular identification of bacteria using ribosomal genes, 
there has also been consideration of molecular identification of yeast using 
ribosomal genes.  In yeast, the ribosomal RNA genes consist of the adjacent 
small subunit (18S rDNA), the internal transcribed spacer 1 (ITS1), the 5.8S, 
the internal transcribed spacer 2 (ITS2), and the large subunit, the last of 
which includes the D1/D2 region at its 5’ end (reviewed by 59,  and 60).  For 
yeast identification, multiple ribosomal target genes have been considered, 
and of these regions, the ITS1, ITS2, and the D1/D2 region have shown to be 
the most useful for species-level identification, as a result of the variability 
within these regions (reviewed by 39, and 60).  In fact, sequence analysis of 
these regions has shown great promise in the practice of clinical mycology 
(16-18, 35, 50, 54, 61).  As with bacterial identification, this method provides 
advantages for identification of slow-growing, biochemically unreactive, and 
unusual yeast isolates. 
 
Summary of results 
 In this work, we used an in vivo mouse model and in vitro molecular 
genetic techniques to examine the effects of the intestinal environment on 
Salmonella invasion.  In chapter 2, we describe the intestinal environment of 
the mouse using 16S rDNA molecular techniques to define the microbiota 
present and HPLC or GC-MS to determine the short chain fatty acids present.  
We defined the normal conditions in the ileum and cecum and also determined 
the changes that occurred upon treatment with streptomycin, infection with 
Salmonella, or upon treatment with streptomycin prior to Salmonella infection.  
Also, we examined the ileum and cecum to determine any histopathological 
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changes in these locations as a result of the streptomycin treatment or 
Salmonella infection.  We found that the microbiota found in the ileum is 
different from that of the cecum.  We also found that streptomycin treatment 
altered the microbial populations in both locations and significantly decreased 
the short chain fatty acid concentrations in the cecum.  Additionally, 
pretreatment with streptomycin prior to Salmonella infection increased the 
pathology observed in the ileum.  The study in Chapter 3 examined the effects 
of propionate and butyrate on Salmonella invasion genes in vitro.  In particular, 
we confirmed that propionate and butyrate repress invasion genes at 
concentrations comparable to that observed in the cecum of the mouse.  We 
also found that metabolization of propionate is necessary for this effect and 
that production of the metabolic intermediate propionyl-CoA is important for 
this effect. 
We also examined the effectiveness of using molecular techniques for 
microbial identification in the clinical veterinary laboratory setting.  In particular, 
in Chapter 4 we investigated the usefulness of sequence analysis of the 
D1/D2 region of the large ribosomal subunit for yeast identification and found 
that it was an effective method of identifying yeast in the clinical veterinary 
laboratory. 
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Perturbation of the small intestine microbial ecology by streptomycin 
alters pathology in a Salmonella enterica serovar Typhimurium murine 
model of infection* 
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ABSTRACT 
The small intestine is an important site of infection for many enteric 
bacterial pathogens, and murine models, including the streptomycin-treated 
mouse model of infection, are frequently used to study these infections.  The 
environment of the mouse small intestine and the microbiota with which 
enteric pathogens are likely to interact, however, has not been well described.  
Therefore, we compared the microbiota and the concentrations of short chain 
fatty acids (SCFAs) present in the ileum and cecum of streptomycin-treated 
mice and untreated controls.  We found that the microbiota in the ileum of 
untreated mice differed greatly from that of the cecum of the same mice, 
primarily among families of the phylum Firmicutes.  Upon treatment with 
streptomycin, substantial changes in the microbial composition occurred, with 
a marked loss of population complexity.  Characterization of the metabolic 
products of the microbiota, the SCFAs, showed that formate was present in 
the ileum but low or not detectable in the cecum while butyrate was present in 
the cecum but not the ileum.  Treatment with streptomycin altered the SCFAs 
in the cecum, significantly decreasing the concentration of acetate, propionate, 
and butyrate.  In this work, we also characterized the pathology of Salmonella 
infection in the ileum.  Infection of streptomycin-treated mice with Salmonella 
was characterized by a significant increase in the relative and absolute levels 
of the pathogen and was associated with more severe ileal inflammation and 
pathology.  Together these results provide a better understanding of the ileal 
environment in the mouse and the changes that occur upon streptomycin 
treatment.  
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INTRODUCTION  
 The small intestine serves as the site of colonization and attachment 
and the seat of pathogenesis for a number of important enteric bacterial 
pathogens of man and animals.  Among the bacteria that cause diarrheal 
disease in the small bowel are Vibrio cholerae, which colonizes the small 
intestine and secretes toxins (64),  and pathogenic forms of Escherichia coli 
including enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), and 
diffusely adherent E. coli (DAEC), all of which either adhere to or affect 
enterocytes in the small intestine (reviewed in 42).  Yersinia enterocolitica and 
Salmonella have also both been shown to preferentially invade the ileum by 
targeting the Peyer’s patches (9, 25).   All of these species must thus survive 
within this region of the intestinal tract in competition with the resident 
microbiota, and must there express determinants necessary for virulence.  
Additionally, the small intestine is an important site for lesions associated with 
inflammatory bowel disease (IBD).  Although the causes of IBD are complex 
and multiple, the microbiota of the small intestine is thought to be important to 
disease development.  It has been alternatively theorized that IBD stems from 
an alteration in the host microbiota present, deficiencies in the host’s response 
to and control of the microbiota, or changes in the function of a particular 
member of the microbiota (reviewed by 65, 72), the last of which supported by 
recent findings suggesting a connection between Crohn’s disease and strains 
of Escherichia coli termed adherent and invasive E. coli (AIEC) (5, 19). 
 The expression of virulence determinants by bacterial pathogens often 
occurs in response to specific environmental cues.  For enteric pathogens 
including EPEC, ETEC, DAEC, and Y. enterocolitica, a temperature near 37°C 
is important for virulence (13, 24, 28, 83).  For EPEC , physiological 
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osmolarity, near neutral pH, and quorum sensing have all been implicated in 
pathogenesis (13, 92).  Toxin production and hence virulence in ETEC is 
regulated by osmolarity and microaerophilic conditions (83) while Dr fimbriae 
production in DAEC is controlled by anaerobic conditions (24).  Invasion by Y. 
enterocolitica is controlled by regulation of the expression of the invasin 
protein by an acidic pH (28).  For Salmonella, low oxygen, log phase growth, 
high osmolarity, and slightly alkaline pH have been shown to positively affect 
expression of genes necessary for Salmonella invasion in vitro (2, 29, 31, 53, 
73).   Additionally, our previous work has shown that short chain fatty acid 
(SCFA) concentrations and pH are important for invasion gene expression.  
The SCFAs acetate and formate induce invasion gene expression, while 
butyrate and propionate repress these same genes at pH levels comparable to 
those of the mammalian intestinal tract (38, 52).  Furthermore, previous in vivo 
studies have shown an association between decreased short chain fatty acids 
and susceptibility to Salmonella infection in a cecectomized mouse model 
(87). 
 Examination of the intestinal environment reveals that enteric 
pathogens are tuned to respond to cues naturally present in the gut.  Host 
temperature is maintained close to 37°C. There exists an axial oxygen 
gradient in the gut, with the lumen of the small intestine and colon being 
anaerobic, whereas the mucosal surface is microaerobic (21).  The osmolality 
of the small intestine in humans is 250-425 mOsmol/kg depending on the 
location within the small intestine and the state of digestion (41, 49). In various 
mammalian species, studies have shown that the SCFAs acetate and 
propionate are found in both the large and small intestine, while butyrate is 
present primarily in the cecum and colon and formate in the ileum (1, 6, 7, 18, 
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50, 51, 61, 67).  Additionally, it is thought that the resident microbiota present 
in the intestinal tract produce quorum sensing molecules that may be 
important for interspecies communication (reviewed by 62).   
 Much of the environment of the intestinal tract is defined by the 
metabolic processes of the bacterial populations that reside within.  There 
have been several recent comprehensive studies that reveal the large 
intestine (the cecum, colon, and feces) of mice and humans to be inhabited by 
a diverse population of bacteria (23, 27, 39, 47, 55, 76, 80, 84).  There are 
1012 microbes/gram of contents in the distal intestinal tract, and it is estimated 
that there are 500-1,000 different species present (22, 90).  Of these species, 
the majority belong to two phyla, the Firmicutes and Bacteroidetes, this being 
true for both mice and humans (27, 55).  Because the intestinal microbiota 
plays a critical role in protecting the host against enteric bacterial pathogens or 
―colonization resistance‖ (85), increased understanding of the composition of 
the intestinal microbiota is essential to defining bacterial pathogenesis.  In 
contrast with the wealth of information now available regarding the 
composition of the large intestinal microbiota, relatively little is known about 
that of the mouse small intestine.   A comprehensive survey of the microbiota 
in the human small intestine has been completed with predominating groups 
consisting of the Firmicutes (Lachnospiraceae and Bacillus) and the 
Bacteroidetes (30).  However, studies in mice consist of a limited survey of the 
microbiota of the ileum (69), examination of bacteria present at the phylum 
level (40), and quantification of particular bacterial groups believed to be 
common inhabitants of the ileum (3). 
 The streptomycin-treated mouse model has proven to be an effective 
method to study enteric disease and has been used to study pathogens such 
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as Vibrio cholerae, enterohemorrhagic E. coli (EHEC), and Salmonella (4, 60, 
64, 88).  It is specifically useful for the study of Salmonella as untreated mice 
develop systemic salmonellosis without an enteric component, but 
pretreatment with oral streptomycin produces enterocolitis (4, 70).  In this 
model of infection, the primary pathology occurs in the cecum, and studies 
have shown that changes in the cecal microbiota occur when mice are 
pretreated with streptomycin (4, 80).  However, the effects of streptomycin 
treatment on the ileum have not been well characterized. 
As the environment of the small intestine is poorly characterized in 
animals used as models of enteric infection, we have in this study 
characterized the bacterial populations, fatty acid composition, and 
histopathological changes of this region in untreated and streptomycin-treated 
mice, both uninfected and infected with Salmonella enterica serovar 
Typhimurium.  We hypothesized that a unique bacterial population within the 
ileum, and the environment created by the population, would be important for 
the protection of the host against invading pathogens.  We show here that 
there exists a stable bacterial community within the ileum that is different from 
that of the cecum, and that the microbial population associated with the ileal 
mucosa is different from that of the lumenal contents.  Additionally, we find 
that streptomycin treatment alters the microbial populations associated with 
both the ileum and cecum by decreasing species richness and changing the 
distribution of phylotypes present.  We also find that streptomycin pretreatment 
allows Salmonella to overcome colonization resistance, increasing by two logs 
the number of Salmonella present at this intestinal site in treated animals, and 
thus alters the pathologic response of the ileum to Salmonella infection.  
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MATERIALS AND METHODS 
Mouse experiments.  For infection experiments, a spontaneous streptomycin-
resistant isolate of Salmonella enterica serovar Typhimurium strain ATCC 
14028s was used.  Twenty-five milliliters of culture was grown overnight with 
aeration at 37°C in MOPS minimal media with 0.5% glucose (63).  The 
bacteria were then pelleted, washed three times with PBS, and resuspended 
in 1 ml of PBS.  Fifty microliters was then used to infect each mouse, equaling 
a dose of ~109 Salmonella per mouse.   All mouse experiments were 
approved by the Institutional Care and Use Committee at Cornell University.  
Seven-week-old female C57BL/6 mice were obtained from Charles River 
Laboratories for all experiments and housed in a containment facility for 
pathogens.  Mice were housed three to a cage and fed a standard laboratory 
diet.  Mice were divided into two groups of twelve, with one group inoculated 
orally with 30 µl of sterile water and the other with 30 μl of sterile streptomycin 
sulfate solution (20 mg per mouse).  Twenty-four hours later, six mice in each 
group of twelve were inoculated orally with 50 μl of sterile PBS, and the 
remaining six from each group received 50 µl of Salmonella at a total dosage 
of ~109 cfu.  Forty-eight hours after infection with Salmonella mice were 
euthanized and tissues were collected from the ileum and the cecum of each 
mouse. 
DNA isolation.  Samples from the distal ileum and cecum containing both 
tissue and contents were collected and placed in bead tubes (MO BIO 
Laboratories, Inc., Carlsbad, CA), whereas samples of intestinal contents were 
carefully expressed into microcentrifuge tubes without scraping the mucosa.  
The mass was determined and the samples were then flash frozen with liquid 
nitrogen.  Samples were stored at -80°C until they were processed.  Total 
   
27 
DNA was isolated from samples using a modified version of the Qiagen 
DNeasy Blood and Tissue Kit (Qiagen).    Briefly, 360 µl of Buffer ATL was 
added to samples in their bead tubes and then homogenized for one minute 
using a Mini-Bead-Beater (BioSpec Products, Inc., Bartlesville, OK), a method 
of mechanical disruption that has been shown effective for the isolation of 
bacterial DNA from fecal samples (56).  Then 40 µl of proteinase K was added 
and samples were vortexed.  Samples were then processed as described in 
the manufacturer’s protocol with one change:  prior to the addition of 200 µl of 
100% ethanol the samples were incubated at 70°C for 30 minutes. Samples of 
intestinal contents were processed similarly except that bead tubes were not 
used. 
16S rRNA gene clone library construction and analysis.  Clone libraries of 
16S rRNA-encoding genes were constructed as previously described (91).  
Briefly, primers 8F and 1492R were used to amplify the 16S rRNA-encoding 
genes from the DNA samples (75).  For cecal samples, 20 cycles were used 
for PCR, whereas 24 cycles were used for ileal samples due to the lower 
concentration of bacterial DNA present in the ileum.  The increase in cycles 
allowed for amplification from all but 3 ileal samples among the various 
treatment groups.  For the samples that did not amplify, there appeared to be 
a lower concentration of bacterial DNA leading to mispriming with mouse DNA, 
which interfered with clone library construction.  Purified PCR products were 
then ligated into a T-tailed cloning vector (pCR 4-TOPO; Invitrogen) and used 
to transform competent cells.  Ninety-four clones per library were sequenced 
by the Cornell University Sequencing Facility using the 8F primer.  Sequences 
were then uploaded to the Ribosomal Database Project (RDP, 
http://rdp.cme.msu.edu) and the pipeline tool available via myRDP was used 
   
28 
for quality analysis and alignment (14).  The RDP classifier (89), using the 
default 80% confidence threshold setting, and SeqMatch (14) were then used 
for taxonomic classification of the aligned sequences.  Additionally, distance 
matrices were generated from the RDP-based sequence alignments and 
analyzed using the DOTUR program (74).   Using a level of 97% sequence 
identity, DOTUR was used to assign sequences to OTUs, generate rarefaction 
curves, and calculate diversity indices.  To determine the Bray-Curtis measure 
of β-diversity, the program EstimateS was utilized (15).  All sequences 
generated in this study have been submitted to Genbank with accession 
numbers FJ834458-FJ838647. 
Quantitative real-time PCR.  The same DNA used for 16S rRNA gene clone 
library construction was used for quantitative real-time PCR.  The 16S rRNA-
encoding gene was used as the target to measure total bacteria and total 
Salmonella present in each sample as previously described (3), except for the 
bacterial strains used as assay standards.  For assays of total bacteria, we 
used E. coli MG1655 as the standard, and for total Salmonella we used 
Salmonella enterica serovar Typhimurium ATCC 14028s.  Standard curves 
were constructed using these strains to quantify the total number of 16S rRNA 
gene copies per sample, with R2 values of ≥ 0.995 extending to 1,000 copies 
of 16S rRNA-encoding genes for total bacteria and 1 copy for Salmonella, 
defining the lower limits of the test.  For each sample, copies of 16S rRNA-
encoding genes per gram of tissue were calculated using the mass of the 
original sample.   
Short chain fatty acid analysis and pH determination.  Gas 
chromatography-mass spectrometry (GC-MS) was used to quantify short 
chain fatty acids (SCFAs) in the cecum.  Intestinal contents from the cecum 
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were collected in 1% acidified water.  The mass of samples was determined, 
and they were then flash frozen in liquid nitrogen.  Samples were processed 
using a modified version of a previously published protocol (66).  Samples 
were thawed at room temperature, vortexed for one minute, and then 
centrifuged.  The supernatant was removed and placed in a 4 ml glass vial 
(National Scientific, Rockwood, TN) containing 50 µl each of 20 mM stock 
isotopes, [2H3] – and [1-
13C]acetate (Cambridge Isotope Laboratories, Inc., 
Andover, MA),  [2H5]propionate (Cambridge Isotope Laboratories, Inc., 
Andover, MA) , and [13C4]butyrate (Sigma-Aldrich), which were used as 
internal standards for each sample.   Samples were acidified with 10 µl HCl 
and then extracted with 1 ml of diethyl ether four times.  One ml of sample was 
placed in a separate tube containing 2.5 µl of the derivatization reagent 1-tert-
butyl-dimethyl-silyl-imidazole (Sigma-Aldrich) and heated at 60°C for 30 
minutes.  The derivatization step was performed on duplicate aliquots for each 
sample.  Samples were then transferred to autosampler tubes, and analyses 
were performed on a Jeol GCMate II MS with an Agilent 6890N GC inlet 
equipped with a J&W Scientific DB-5MS column (30 m x 0.250 mm, 0.25 
micron film thickness).  A split injector was used with 250°C injector 
temperature and 50:1 split ratio. The initial oven temperature was 60°C held 
for 1 minute followed by a 5°C/min ramp to 120°C and a 25°C/min ramp to 
270°C final temperature, which was held for 1 minute. Total run time was 20 
minutes including a 3.5 min solvent delay. The derivatized acids were detected 
using unit-mass resolution selected ion monitoring (SIM) with magnetic field 
switching at 0.21 sec cycle time on "flat-top" mass peaks with fully open 
collector slit: formate (R.T. 3.98, SIM 3-4.5 min, m/z 75 and 103), acetate (R.T. 
4.91/4.95, SIM 4.5-6.4 min, m/z 75, 117, and 121), propionate (R.T.  6.82/6.9, 
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SIM 6.4-7.5, m/z 75, 131, and 136), and butyrate (R.T. 9.07, SIM 7.5-20 min, 
m/z 75, 145, and 149). The timing and ions for the SIM program were selected 
based on 35-500 m/z full scans on standard samples.  The isotopic internal 
standards were then used for quantification of the SCFAs in each sample.  As 
a result of limitations with the protocol and the small quantity of intestinal 
contents in the small intestine of mice, we used HPLC to quantify all SCFAs in 
the ileum and formate in the cecum.  HPLC and pH determinations were 
performed as previously described (38) except that a micro-combination pH 
probe (Microelectrodes, Inc., Bedford, NH) was used.  For both GC-MS and 
HPLC analyses, sample preparation included steps to remove bacteria without 
lysis, and so SCFA concentrations reflect those of the intestinal milieu.   
Tissue collection and histology.  The distal ileum (~4.0 cm) and cecum 
were harvested and fixed in 10% neutral buffered formalin, embedded in 
paraffin, and the entire length was sectioned at 5 µm thickness and stained 
with haematoxylin and eosin (H&E) for histopathological assessment.  
Sections of ileum were scored on a scale of 0 to 4 for the presence and 
distribution of polymorphonuclear leukocytes in five regions: (i) within the 
lamina propria of the intestinal mucosa, (ii) inside the intestinal crypts 
(cryptitis), (iii) at the periphery of Peyer’s patches, (iv) within the interfollicular 
regions of Peyer’s patches, and (v) within the subepithelial dome areas of 
Peyer’s patches (0, none; 1, rare; 2, few scattered; 3, many groups; 4, large 
numbers) by a board-certified blinded veterinary pathologist.  Ileitis severity 
was calculated as a sum of the scores for the five categorical parameters 
(maximum of 20).  The scoring method is a modification of a method used 
previously (58), and histological designations for each scoring region are 
widely accepted and consistent with previously published work (10). 
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Statistical analysis.  Analysis of short chain fatty acid concentrations was 
completed using the Wilcoxon rank-sum test.  For qPCR and pH, the Kruskall-
Wallis test was used to determine whether there was a significant difference 
among any of the groups, and then the Wilcoxon rank-sum test using a 
Bonferroni correction was utilized to determine significance between individual 
groups.  Similarly, for the pathology scores, the Kruskall-Wallis test and then 
Dunn’s post-test were performed.  A p-value <0.05 was considered significant.  
Statistical analysis was performed using Jmp 7.0 software (SAS, Cary, NC) or 
GraphPad Prism version 5 (GraphPad Software, La Jolla, CA).   
 
RESULTS 
The mouse ileum harbors a defined microbial population.  To increase our 
understanding of the mouse model of enteric infection and the potential 
interaction of pathogens with both the host and the resident microbiota in the 
small intestine, we first characterized the bacteria of the most distal segment, 
the ileum, using conventional mice and a culture-independent method.  Ileal 
and cecal samples, including both tissue and contents, were taken from 
C57BL/6 mice, and 16S rRNA gene clone libraries were created from these 
samples.  We analyzed a total of 536 partial rRNA-encoding gene sequences 
from the ileum and 533 from the cecum.  The clone libraries of the cecum 
were examined to provide a point of reference for our characterization of the 
ileum, since much work has previously been done to characterize the 
microbiota of the cecum (47, 55, 80, 84).  From these sequences, we 
determined that there exists a bacterial community within the ileum that 
consists primarily of the phyla Firmicutes (82%) and Bacteroidetes (16%).  At 
the taxonomic level of family, the most predominant Firmicutes were of the 
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families Clostridiaceae (34%), Lactobacillaceae (24%), and Lachnospiraceae 
(17%) (Fig. 2.1A).  Of the Clostridiaceae, the most predominant clones (32% 
of the total bacterial population) had high sequence identity with a bacterial 
group termed the segmented filamentous bacteria (SFB).  The SFB have 
previously been described as unculturable bacteria that are closely associated 
with the ileal epithelium (20).  Previous phylogenetic analysis has also shown 
the SFB to be most closely related to the genus Clostridium, a member of the 
family Clostridiaceae (78).  Thus, SFB constituted a substantial portion of the 
ileal microbiota.  In contrast to the bacterial composition of the ileum, the 
predominant family of the Firmicutes in the cecum was the Lachnospiraceae 
(52%), a member of the order Clostridiales, while merely 1% of the cecal 
microbiota consisted of the Lactobacillaceae and less than 1% of the 
Clostridiaceae (Fig. 2.1A).  These differences between the bacterial 
composition of the ileum and that of the cecum at the family level suggest that 
there is a defined microbial community in the ileum that differs greatly from 
that found in the cecum.   
Rarefaction analysis was next used both to identify differences in 
richness among the microbial populations of the cecum and ileum and to 
assess the efficacy of our sampling technique in obtaining representative 
samples from both of these sites (34, 36).  This analysis revealed that the 
ileum had lower overall species richness compared to that of the cecum, with 
observed operational taxonomic units (OTUs) of 67 and 156, respectively 
(Table 2.1 and Fig. 2.2A).  The analysis, however, also suggested an under-
representation of the number of OTUs present at both sites, as shown by the 
positive slope of the curves in Fig. 2.2A and the Chao1 analysis of estimated 
richness (11, 12) (Table 2.1).  This was nevertheless not surprising, as much
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Figure 2.1. The microbial composition of the ileum.  16S rRNA gene clone 
libraries were created from the ileum and cecum of C57BL/6 mice.  (A) 
Taxonomic analysis of the clone library sequences was performed using RDP 
Classifier and SeqMatch.  Assignment to the phylum level for the sequences 
from the ileum and cecum of untreated mice is displayed with further 
distinction among the phylum Firmicutes to the family level.  The total of the 
Firmicutes is shown by the arc extending around the pie chart.  (B) Cluster 
analysis of the Bray-Curtis distance measure of diversity between the 
microbial communities for the ileum and cecum from untreated mice.  For the 
Bray-Curtis distance measure an operational taxonomic unit (OTU) was 
defined as 97% sequence similarity.  (C) 16S rRNA gene clone libraries were 
created from samples containing ileal tissue and contents or contents alone 
from untreated mice.  Sequences were assigned to OTUs using a definition of 
97% sequence similarity.  A heatmap is used to show the relative abundance 
of OTUs, with specific OTUs detected in the sample oriented along the 
horizontal axis, and the dendogram showing the distribution of OTUs.  Darker 
coloring within the heatmap indicates greater representation of specific OTUs.  
Phyla are shown above the figure and highly represented OTUs are shown 
below.  Numbers 1-6 and 16P-18P represent individual mice. 
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Table 2.1. Observed and estimated operational taxonomic units (OTUs) 
 
 
Sample  
 
Number of 
OTUs 
 
Chao1 Richness Estimator  
(95% Confidence Interval) 
 
Ileum  
 
67 
 
152 (101-282) 
 
Ileal Contents 
 
9 
 
12 (9-32) 
 
Ileum, Streptomycin-
treated 
 
49 
 
62 (53-93) 
 
Cecum 
 
156 
 
227 (194-288) 
 
Cecum, Streptomycin-
treated 
 
97 
 
138 (115-189) 
 
 
 
is still unknown about the complete microbial richness of the intestinal tract.  In 
addition to taxonomic analysis and determination of species richness, we next 
examined the diversity of the ileal and cecal samples using the Bray Curtis 
distance measure of diversity (57).   Cluster analysis of the Bray Curtis 
distance using an OTU definition of 97% sequence similarity showed that the 
ileal samples clustered with each other, but separately from samples derived 
from the cecum (Fig. 2.1B).  This analysis demonstrated that there were 
differences in the distribution of microbial OTUs in the ileal and cecal samples, 
and that the ileal sample taken from each mouse was more similar to other 
ileal samples than it was to the cecal sample taken from the same mouse.  
Together these analyses show that there is a unique microbial population 
associated with the ileum that is different from that of the cecum.  
Previous work in humans has shown that the microbial population 
associated with the feces is different from that of the colonic tissue (27).  Thus, 
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Figure 2.2. Streptomycin treatment alters the microbial composition of 
both the ileum and the cecum.   (A) Rarefaction analysis and 95% 
confidence intervals are shown for the 16S rRNA-encoding sequences 
obtained from each site in the untreated and streptomycin-treated mice.  
Central lines represent rarefaction analysis of each site with the surrounding 
lines representing the upper and lower 95% confidence intervals.  For 
rarefaction analysis an operational taxonomic unit (OTU) was defined as 97% 
sequence similarity.  (B) 16S rRNA gene clone libraries were created from 
samples containing ileal tissue and contents from untreated mice and those 
pretreated with streptomycin.  Sequences were assigned to OTUs using a 
definition of 97% sequence similarity.  A heatmap is used to show the relative 
abundance of OTUs, with specific OTUs detected in the sample oriented along 
the horizontal axis, and the dendogram showing the distribution of OTUs.  
Darker coloring within the heatmap indicates greater representation of specific 
OTUs.  Phyla are shown above the figure and highly represented OTUs are 
shown below.  Untreated mice shown in this figure are the same as those 
shown in Fig. 1C. 
 
 
we further characterized the ileum to determine whether differences existed 
between the population of bacteria present within the intestinal contents and 
that associated with the ileal tissue.  Samples containing ileal contents but not 
the tissue of the ileum itself were taken from three C57BL/6 mice, and 238 
16S rRNA gene clones were compared to those derived from ileal samples 
containing both tissue and contents.  We found that there was decreased 
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species richness in the samples that contained only contents (Fig. 2.1C and 
Fig. 2.2A).  The total number of OTUs observed was nine in the samples 
containing only contents, compared to 67 in the samples that included both 
tissue and contents.  Additionally, analysis utilizing the Chao1 richness 
estimator further supported this difference in the richness of OTUs, with no 
overlap in the 95% confidence intervals (CIs) (Table 2.1).  Furthermore, the 
Shannon–Weiner Diversity Index, an indicator of diversity within a population 
(57), was 2.87 in samples that included both tissue and contents compared to 
0.98 in samples that contained only contents, indicating lower diversity within 
the bacterial community derived from the contents of the ileum.  Analysis of 
the composition of OTUs present in the ileum (Fig. 2.1C) also showed that 
there was a larger number of OTUs present in the samples containing both 
tissue and contents, and that there was a difference in the distribution of these 
OTUs. Specifically, we found upon comparison that the relative abundance of 
the SFB was much lower in the samples containing only contents, 3% ± 2.6 
compared to 31% ± 13 in samples with both tissue and contents.  These 
results are consistent with previous reports of the SFB being closely 
associated with the ileal epithelium (20).  Thus, these results show that there 
is greater bacterial diversity in the samples that contain tissue and contents 
when compared to those that contain contents alone and suggest the 
presence of a diverse bacterial population in close association with the 
intestinal mucosa.   
Streptomycin alters the microbiota of the ileum.  To better understand the 
streptomycin-treated mouse model of infection and specifically the potential 
changes that occur in the small intestine, we next characterized the microbiota 
of the ileum in streptomycin-treated mice using 16S rRNA gene clone libraries.  
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Mice were treated orally with streptomycin, and samples from the ileum and 
cecum were obtained 72 hours after that treatment.   A total of 503 and 545 
sequences were analyzed from the ileum and cecum of these mice, 
respectively.   To allow comparisons with the untreated mice described in the 
previous section, we performed the two experiments simultaneously, using 
animals obtained as a single lot.  We found that streptomycin treatment altered 
the composition of microbial communities in both the ileum and the cecum.  
Rarefaction analysis demonstrated that streptomycin treatment decreased 
species richness in both the ileum and cecum (Fig. 2.2A).  In this case, the 
Chao1 estimator of richness supported this conclusion as well, as there was 
no overlap in the 95% CIs of the Chao1 of the treated sites when compared to 
the respective untreated sites (Table 2.1).  We also examined the total number 
of 16S rRNA-encoding genes/gram in the ileum and cecum using qPCR.  
Interestingly, we found that there was a ten-fold decrease in bacterial 
numbers, from 109 to 108 16S rRNA gene copies/gram, in the ileum but that 
there was no significant change in the cecum.  Additionally, the Bray-Curtis 
distance measure of diversity between the microbial communities showed that 
in both the ileum and the cecum the majority of samples from untreated mice 
clustered together but separately from the respective samples taken from 
streptomycin-treated mice (data not shown).  Collectively, these results show 
that streptomycin treatment caused a decrease in the richness of the OTUs as 
well as altered the distribution of OTUs in the majority of mice.  Some variation 
did occur within the groups.  Specifically, for one mouse in the group that had 
not been treated with streptomycin, cluster analysis of both the ileum and 
cecum placed the composition of the microbiota between those of the other 
untreated mice and those of the streptomycin-treated group (not shown).  
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These results thus show variation among individual animals but demonstrate 
differences between the treated and untreated groups.  Among ileal samples, 
we found that changes due to streptomycin treatment were not uniform among 
individual mice, with differing OTUs predominating after treatment with this 
antimicrobial.  In particular, two mice had a single family of organisms 
predominate after treatment that was different from the other, in one case the 
family Lachnospiraceae and in the other the family Deferribacteraceae, 
whereas the remaining mice did not have a particular predominating group.  
Therefore, to further analyze these population changes we did not combine 
these libraries of sequences but instead characterized the changes in the 
ileum caused by streptomycin by examining the microbiota of individual mice 
for the presence and prevalence of specific OTUs (Fig. 2.2B; untreated mice 
shown in this figure are the same as those shown in Fig. 2.1C).  Overall, there 
were changes in the distribution of OTUs as well as in the relative abundance 
of particular OTUs.  More specifically, there was a decrease in the relative 
abundance of the SFB in the streptomycin-treated mice, 3% ± 4 as compared 
to 31% ± 13 in the ileum of untreated mice, consistent with previous reports 
that this group of bacteria is sensitive to streptomycin (43). 
Streptomycin pretreatment enhances Salmonella infection of the ileum.  
In the murine model of Salmonella infection, streptomycin treatment has been 
shown to enhance infection of the cecum (4, 80), but little is known about 
effects on the small intestine.  We therefore next characterized the microbiota 
in the ileum of mice infected with Salmonella to determine whether infection 
was also altered in this region of the intestinal tract.  C57BL/6 mice were 
pretreated orally with either sterile water or streptomycin, and 24 hours later 
both groups were orally infected with a streptomycin-resistant strain of 
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Salmonella.  To examine the microbiota present in each of these groups, 16S 
rRNA gene clone libraries were created.  A sufficient bacterial DNA 
concentration for clone library construction was obtained from 5 of 6 untreated 
mice and 4 of 6 streptomycin-treated mice, for a total of 452 and 362 
sequences from the respective groups.  Taxonomic analysis of these clone 
libraries showed that only one animal in the untreated group had detectable 
Salmonella in the ileum, with one Salmonella 16S rRNA containing clone 
identified among the 86 clones sequenced (not shown).  In contrast, for mice 
pretreated with streptomycin prior to infection, 2-97% of the total bacterial 
population observed in the ileum consisted of Salmonella.  To more precisely 
determine the extent of Salmonella infection of the ileum, we used qPCR to 
determine the number of Salmonella-specific 16S rRNA gene sequences 
present.  We were able to detect Salmonella in all of the animals, whether or 
not they were pretreated with streptomycin, but found that streptomycin 
treatment significantly increased the number of Salmonella at this site (p-
value<0.05).  The number of copies of the Salmonella 16S rRNA gene per 
gram of tissue was increased in streptomycin-treated animals, with a median 
in pretreated mice of 4x106, more than two logs greater than that of the 
untreated mice, having a median of 1x104.  There was, however, much 
variation among individual animals, with the number of Salmonella obtained 
from mice treated with streptomycin prior to infection ranging from 5x105 to 
6x108 copies/gram of tissue (Fig. 2.3).  One possible explanation for this 
variation could be varying levels of Salmonella infection in these mice.  
However, histopathological examination confirmed the presence of severe 
diffuse colitis similar to that previously reported in mice orally administered 
streptomycin prior to infection (4).  Mucosal damage and inflammation ranged  
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Figure 2.3. Streptomycin pretreatment increases Salmonella infection of 
the ileum.  Real-time PCR was used to compare the number of Salmonella in 
the ilea of individual mice without additional treatment to those pretreated with 
oral streptomycin.  The number of copies of the Salmonella 16S rRNA gene 
amplified using Salmonella-specific primers was determined and is shown 
relative to the mass of the ileal sample.  The limit of detection for Salmonella 
was one copy/100 ng total DNA.  Represented adjacent to the circles are the 
number of Salmonella 16S rRNA gene sequences identified over the total size 
of the clone library analyzed from this same animal.  Circles with nd (not 
determined) show animals in which clone libraries could not be produced, 
primarily due to low bacterial DNA yields.  Horizontal lines represent the 
median for each group. 
 
 
from moderate and multifocal in one mouse to severe and focally extensive or 
diffuse in the other mice (not shown).   Therefore, taken together these results 
show that, although variation exists in the number of Salmonella able to 
colonize the ileum, pretreatment with streptomycin significantly alters the 
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composition of the ileal microbiota and leads to enhanced survival and 
colonization of Salmonella in this important region of the intestine. 
Streptomycin treatment alters the fatty acid composition of the intestine.  
Since there are differences in the microbiota found in the ileum and cecum, we 
next considered whether these differences might manifest themselves as 
variations in the presence and concentrations of SCFAs in each intestinal 
location, suggesting a possible means by which Salmonella virulence might be 
modulated in vivo, as SCFAs have been shown to have differing effects on 
Salmonella invasion depending upon their composition and concentration (38, 
52).  We therefore characterized the SCFAs in these regions of the intestine 
using GC-MS and HPLC.  As anticipated, there were significant differences in 
the SCFAs present in the ileum and cecum.  We found that formate, previously 
identified as a positive signal for Salmonella invasion in vitro, was present in 
the ileum at a median concentration of 8.1 mM, but was low or below the level 
of detection (median concentration of 0 mM) in the cecum (Fig. 2.4).  In 
contrast, butyrate, previously shown to be a negative signal for invasion, was 
not detectable in the ileum but was present in the cecum at a median 
concentration of 12.8 mM (Fig. 2.4).  We also determined the pH of the 
intestinal lumen, as acidity affects the penetration of SCFAs into bacteria and 
thus their effects on gene expression.  The median pH of the ileum was 6.68 
and that of the cecum was 6.39, both at levels below neutrality, thus promoting 
increased bacterial uptake of SCFAs.   
Since alterations in the microbiota occur with streptomycin treatment, 
and the microbiota produces SCFAs, we next determined whether changes 
occurred to the SCFA concentrations as a result of this treatment.  We found  
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Figure 2.4. Short chain fatty acids of the untreated and streptomycin 
treated ileum and cecum.  Intestinal contents were collected from the ileum 
and cecum of both untreated and streptomycin-treated mice 72 hours after 
treatment.  SCFAs were quantified using (A) HPLC analysis for the ileum, or 
(B) GC-MS for the cecum.  The box plots show the median with 25% and 75% 
quartiles.  The bars in each box plot extend to the outermost points located 
within the quartile ± 1.5 X the interquartile range.  An asterisk (*) indicates 
significant difference at a p-value<0.01 between the untreated mice and 
streptomycin-treated mice for short chain fatty acid concentrations. 
 
 
that streptomycin treatment altered the SCFAs of the cecum, with a significant 
decrease in acetate, propionate, and butyrate, but did not significantly alter the 
SCFAs of the ileum or the pH of either site (Fig. 2.4 and not shown).  The 
median acetate concentration was substantially reduced, from 42.0 mM to 9.4 
mM, and the median butyrate concentration from 12.8 mM to 1.0 mM in the 
cecum, while the median propionate concentration was more modestly 
reduced from 8.5 mM to 5.4 mM.   These results, taken with previous findings, 
show that SCFAs exist in concentrations capable of signaling the modulation 
of Salmonella virulence.  Additionally, the results suggest that the ileal 
environment in normal mice is conducive to tissue invasion, while that of the 
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cecum represses invasion, but that treatment with streptomycin alters the 
environment of the cecum to reduce repressive signals, perhaps explaining 
the cecal pathology that is commonly observed during Salmonella infection of 
streptomycin-treated mice.  
Streptomycin treatment prior to infection with Salmonella enhances ileal 
inflammation. Previous work on the streptomycin-treated mouse model of 
Salmonella infection primarily focused on development of severe colitis without 
detailed examination of the ileum (4).  Therefore, we characterized the 
histopathological changes present in the ileum of control mice and mice 
infected with Salmonella with and without oral administration of streptomycin.  
When compared to mice infected with Salmonella without antibiotic treatment, 
streptomycin administration prior to infection with Salmonella enhanced the 
extent and degree of inflammation present in the distal ileum (Fig. 2.5 and 
2.6).   Five of the six mice administered streptomycin prior to Salmonella 
showed multifocal to segmental infiltration of the lamina propria at the base of 
intestinal crypts by clusters of polymorphonuclear neutrophils accompanied by 
epithelial cell damage and cryptitis (Fig. 2.5).  Similarly, large numbers of 
neutrophils were present within interfollicular regions and at the periphery of 
Peyer’s patches extending into the lamina propria of adjacent mucosa.  In 
contrast, mice infected with Salmonella without streptomycin pretreatment had 
only few neutrophils admixed with few eosinophils at the periphery of Peyer’s 
patches (6 of 6 mice) and interfollicular regions (2 of 6 mice). The subepithelial 
dome areas of Peyer’s patches in 3 of 6 mice inoculated with Salmonella after 
oral streptomycin administration also were markedly expanded by large 
numbers of neutrophils, a change that was absent in mice from the other 
groups (Figs. 2.5 and 2.6).  Moreover, the follicle-associated epithelium  
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Figure 2.5. Streptomycin administration prior to infection with 
Salmonella enhances the extent and degree of ileal inflammation in mice. 
Hematoxylin and eosin-stained ileum was obtained from mice pretreated with 
streptomycin and infected with Salmonella.  A) Necrosis of ileal villi 
accompanied by focally extensive infiltration of lamina propria by large 
numbers of polymorphonuclear neutrophils extending along the base of 
intestinal crypts; 12X magnification. B) Infiltration of villous lamina propria by 
large numbers of polymorphonuclear neutrophils with segmental sloughing of 
intestinal epithelial cells; 20X magnification.  C) Infiltration of ileal Peyer’s 
patch subepithelial dome area by large numbers of polymorphonuclear 
neutrophils (asterisk) together with focal disruption of the follicle-associated 
epithelium (arrowhead) and transepithelial migration of neutrophils; 20X 
magnification. 
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Figure 2.6. Streptomycin administration prior to infection with 
Salmonella is associated with ileal Peyer’s patch inflammation in mice. 
Hematoxylin and eosin-stained ileal Peyer’s patches of uninfected mice and 
mice infected with Salmonella with and without streptomycin pretreatment. (A-
B) untreated and uninfected, (C-D) streptomycin-treated, (E-F) Salmonella-
infected, (G-H) streptomycin-treated and Salmonella–infected. The 
subepithelial dome area is diffusely infiltrated by large numbers of 
polymorphonuclear neutrophils in the streptomycin-treated and Salmonella-
infected mouse (G-H, asterisks), while the follicle-associated epithelium is 
markedly attenuated in mice infected with Salmonella with (H, arrowhead) or 
without (F, arrowhead) streptomycin compared with tall columnar epithelium in 
uninfected mice (B,D, arrowheads). The streptomycin-treated and Salmonella-
infected mouse also displays focal disruption of the follicle-associated 
epithelium along with multifocal transepithelial migration of polymorphonuclear 
neutrophils and focal cypt abscess (H, arrow). (A,C,E and G, 6X magnification; 
B,D,F and H, 12X magnification).
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overlying the dome areas of ileal Peyer’s patches of mice receiving 
streptomycin with or without Salmonella was diffusely low cuboidal compared 
to tall columnar epithelium in untreated control mice (Fig. 2.6).  To better 
quantify histopathological changes in the ileum of mice in each of the four 
treatment groups, lesions were scored on a 0 to 4 scale, and ileitis severity 
was calculated as the sum of the scores for the five categorical parameters 
described in Materials and Methods, with 20 representing maximum severity.  
Using this scoring system, the median score for untreated mice was 1, while 
those that had received both streptomycin and Salmonella and displaying 
ileitis had a median score of 15 (p-value<0.05).  Slight increases in ileal 
pathology was present in groups that received Salmonella or streptomycin 
alone (medians of 4.5 and 7, respectively), but these differences were not 
significantly different from untreated mice.  In addition to the ileal mucosal 
changes, histopathological examination of the ileum revealed a complete 
absence of long filamentous bacteria in the lumen of the ileum of mice treated 
with streptomycin with or without Salmonella infection (not shown).  These 
results are thus consistent with the microbial ecology data demonstrating a 
decrease in the numbers of SFB in mice receiving streptomycin and show that 
antibiotic administration exacerbates the pathology of the ileum caused by 
Salmonella.   
 
DISCUSSION 
 There has been much recent work describing the bacterial composition 
and chemical environment of the large intestine, including the cecum, colon, 
and feces, but relatively little is known about the comparable conditions of the 
small intestine.  In this work we have characterized the ileum of the mouse, 
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the species used frequently as a model of infection for many of the enteric 
bacterial pathogens that cause disease in the small intestine, and have 
examined the effects on this organ of both antibiotic administration and 
infection with Salmonella.   As an effective rodent model of human enteric 
disease requires an understanding of the types of bacteria that normally reside 
within the intestine, we first identified the constituents of the ileal microbiota.  
We found the microbiota of the mouse ileum to be quite different from that of 
the cecum, with the predominant Firmicutes present being the Clostridiaceae, 
Lactobacillaceae, and Lachnospiraceae, while in the cecum the predominant 
family was the Lachnospiraceae, with much lower relative abundance of the 
Lactobacillaceae and Clostridiaceae.  These findings are consistent with 
previous results in humans which showed a similar higher relative abundance 
of the Lachnospiraceae in the large intestine and Lactobacillaceae in the small 
intestine (30).  In contrast to those results, however, our findings also show a 
large relative abundance of the Clostridiaceae in the mouse ileum that was not 
observed in the human small intestine.  In mice, 94% of the bacteria classified 
as Clostridaceae belonged to a group of bacteria called the segmented 
filamentous bacteria (SFB).  The SFB are a group of unculturable, Gram 
variable, long, segmented, and filamentous bacteria that have been shown to 
be closely associated with the ileal epithelium in mice and other vertebrates 
(20, 44).   They have previously been observed in one human ileal sample 
(44), however, less is known about the prevalence in the normal human ileum.  
It is possible that they are not as abundant in the human ileum as in the 
mouse ileum or that more studies are necessary to look specifically for this 
group of bacteria in human samples. 
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 Our characterization of the ileal microbiota also showed that there were 
differences in the microbial population associated with samples containing 
tissue and lumenal contents when compared to those that contained only 
contents.  In the samples containing only contents, there was lower species 
richness, with the majority of bacteria classified within the family 
Lactobacillaceae (Fig. 1C).  This suggests that the great majority of the 
microbial diversity observed in the ileum arises from a population of bacteria 
intimately associated with the intestinal mucosa rather than within the ileal 
lumen.  The increased relative abundance of the Lactobacillaceae in lumenal 
samples could be attributed to several factors.  Previous work using qPCR has 
shown that Lactobacillus is present in quantities between 107 and 109 in the 
distal small intestine (3) indicating that they are a predominant group in this 
location.  Current data give conflicting reports on the ability of Lactobacillus 
species to adhere to the intestinal mucosa (35); therefore, one explanation for 
the relative abundance of Lactobacillaceae in intestinal contents is that the 
Lactobacillaceae may not be as closely associated with the ileal epithelium as 
are members of the Lachnospiraceae, Clostridiaceae, and Bacteroidaceae.  
Supporting this hypothesis is previous work showing that the SFB, members of 
the Clostridiaceae, are very closely associated with the ileal epithelium (20), 
which is consistent with our results showing the relative abundance of the SFB 
in samples containing tissue to be 10-fold greater than that in samples with 
intestinal contents alone.  Additionally, Lactobacillus species have previously 
been shown to be abundant in the upper intestinal tract, including the stomach 
and upper small intestine (71, 82). Thus, the bacterial population in the ileal 
contents may be a transient population consisting primarily of bacteria shed 
from the upper intestinal tract.  The disparity between the microbial 
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composition of the mucosa and that of the contents is important, because 
these results suggest that sampling the intestinal contents alone severely 
under-represents the diversity present in the ileum.   Thus, to fully understand 
the interaction of invading pathogens with the host, it is important to 
characterize the bacteria associated with the mucosa as well as within the 
lumenal contents.  
Upon treatment of mice with streptomycin, we observed changes in the 
composition of the microbiota in both the ileum and cecum.  Specifically, in the 
ileum there was a ten-fold decrease in the SFB.  Previous work has suggested 
a role for the SFB in host pathogen interactions; specifically, they were shown 
to be important in providing protection against Salmonella and EPEC 
colonization of ileal surfaces (33, 37) and for stimulating the mucosal immune 
response in mice (46, 81).  Correlated with this loss of microbiota was the 
enhanced infection of the ileum by Salmonella after treatment with 
streptomycin.  We observed a significant increase in the number of Salmonella 
residing in the ileum in streptomycin-treated mice, suggesting that the 
administration of this antimicrobial alters the ileal environment sufficiently to 
allow improved colonization by the invading pathogen.  In addition to the 
changes in the SFB observed with streptomycin-treatment, we also observed 
inflammation in the ileum of mice treated with streptomycin prior to infection 
with Salmonella that was not seen in animals infected with Salmonella without 
streptomycin treatment.  In this study, mice were infected with Salmonella 24 
hours after streptomycin treatment, while the characterization of the ileal 
environment and microbiota was conducted in streptomycin-treated mice 72 
hours after administration of the antibiotic.   A previous study has shown that 
recovery of the normal microbiota, as measured at the phylum level, occurred 
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five days after streptomycin treatment (80).  Therefore, it is possible that 
antibiotic treatment elicited changes in the numbers of bacterial species not 
observed in this study that contributed to Salmonella colonization.  However, 
even so, these results, along with those of previous studies, suggest a 
possible role for the SFB in preventing colonization and infection of the ileal 
surface of normal mice, either by physically blocking colonization or by 
creating an immune response and thus limiting Salmonella entry to the Peyer’s 
patches and systemic disease.  Although mice mono-associated with SFB 
exist (45), these mice would not allow a full understanding of the interaction 
between the SFB and surrounding commensals with the invading pathogen.  
Thus, further work examining the relationship between the SFB and 
Salmonella infection in the mouse is hampered by the intractable nature of this 
intestinal resident.  In addition to the effects of the microbiota on Salmonella 
infection, the genetic background of the mouse might also play an important 
role.  The strain used in this work, C57BL/6, is Nramp1-/- and thus highly 
susceptible to Salmonella infection.  A previous study noted greater ileal 
inflammation after Salmonella infection in untreated Nramp1+/+ strains in 
comparison to C57BL/6 mice (79), suggesting innate differences in their 
responses to infection.  That work, however, did not examine the effects of 
streptomycin pretreatment on this pathology, and so the relative utility of 
mouse strains for this infection model remains to be investigated.                      
 Short chain fatty acids (SCFAs) are produced by the intestinal 
microbiota and thus are largely responsible for the composition of the intestinal 
chemical environment.  Furthermore, previous work has shown that SCFAs 
affect both viability and virulence gene expression in enteric pathogens (8, 32, 
38, 48, 52, 54, 59, 77, reviewed by 86).  Therefore, in addition to 
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characterizing the microbiota of the ileum and cecum, we also determined the 
SCFA concentrations in these regions to better understand the chemical cues 
likely to be sensed by pathogenic bacteria.  We found that formate was 
present in the ileum, but was in low concentration or was undetectable in the 
cecum, and, conversely, that butyrate was present in the cecum but was not 
detectable in the ileum.  These differences in SCFAs may be a result of the 
variation in the microbiota between these two locations.  For example, the 
family Lachnospiraceae contains genera that are classified as butyrate-
producers (16), and we found that there was a higher relative abundance of 
the Lachnospiraceae in the cecum (52%) when compared to that in the ileum 
(17%).  Additionally, there is higher relative abundance of the Lactobacillaceae 
in the ileum (24%) when compared to the cecum (1%), and under certain 
conditions species of Lactobacillus have been shown to be 
heterofermentative, producing formate and acetate in addition to lactic acid 
(17, 68).  Upon treatment with streptomycin, we observed significant changes 
in the SCFA concentrations in the cecum as was previously observed (67), 
however, we observed more substantial decreases in both the acetate and 
butyrate concentrations than were previously reported.  It is likely that these 
changes in SCFAs occurred as a result of the changes in the microbiota in this 
region.  Interestingly, at the family level, there did not appear to be a change in 
the relative abundance of the Lachnospiraceae, which contains several 
butyrate-producers.  However, we did observe decreased species richness 
and a change in the distribution of phylotypes at the level of 97% sequence 
similarity in the cecum of streptomycin-treated mice.  These results suggest 
changes at the species level; thus, it is possible that there were changes in the 
relative abundance of the butyrate-producing species present within the family 
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Lachnospiraceae leading to the changes in the butyrate concentration in the 
cecum.  Another possibility is that streptomycin eliminates a particular group of 
bacteria important for acetate production.  Previous work has shown that some 
butyrate-producers use exogenous acetate for butyrate production (26); 
therefore a decrease in the population of acetate producing bacteria could 
potentially lead to a decrease in both acetate and butyrate.  Thus, it is possible 
that the changes in microbiota as a result of streptomycin treatment produced 
these changes in SCFA concentrations in the cecum.     
On the basis of previous in vitro observations indicating modulation of 
Salmonella invasion gene expression by certain SCFAs, we hypothesized that 
alterations in the microbiota associated with streptomycin administration and 
the resulting changes in relative concentrations of SCFAs in the intestinal tract 
may affect the pathogenesis of Salmonella infection in the mouse model.  
Previous in vitro work from our laboratory and those of others has shown that 
specific SCFAs can positively or negatively affect the expression of 
Salmonella invasion genes.  In particular, formate has been characterized as a 
positive signal and butyrate a negative signal (8, 32, 38, 52).  Since in the 
mouse model of infection Salmonella invades primarily in the ileum, in 
particular the Peyer’s patches, causing septicemia (9, 70), the observation that 
formate is detectable in the ileum and not the cecum suggests that it may be 
an important positive signal in vivo for Salmonella invasion gene expression.  
In contrast, the presence of butyrate in the cecum and not the ileum suggests 
that it may be an important negative signal in vivo.  Therefore, these results, 
along with previously published results in cecectomized mice (87), indicate 
that the distribution and abundance of the SCFAs in the intestinal tract may 
play an important role in Salmonella virulence.  Upon treatment with 
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streptomycin prior to Salmonella infection, there are changes in the intestinal 
pathology, with the appearance of pronounced cecal inflammation (4), and, as 
shown in this work, exacerbated pathology of the ileum as well.  Changes in 
the ileum cannot be attributed to alterations in the concentrations of SCFAs 
present at this site, as untreated mice have a SCFA composition that is likely 
already conducive to bacterial invasion, and streptomycin treatment did not 
elicit a change in that composition.  In contrast, the cecal contents of treated 
mice showed a significant reduction in SCFA concentrations, with butyrate 
being substantially reduced.  These results thus suggest that streptomycin-
treatment prior to infection decreases the negative signal provided by butyrate, 
allowing Salmonella invasion in the cecum and the cecal pathology observed 
in this infection model. 
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CHAPTER 3 
Repression of Salmonella invasion by the intestinal fatty acid propionate 
requires production of the high-energy intermediate propionyl-CoA 
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ABSTRACT 
Salmonella is a causative agent of food-borne illness.  To cause 
disease, it must first invade the intestinal epithelium using genes encoded on 
Salmonella Pathogenicity Island 1 (SPI 1).  Previous work in our lab has 
shown that the short chain fatty acids, propionate and butyrate, negatively 
regulate SPI 1 invasion gene expression in vitro.  Additionally, our previous in 
vivo work also showed a correlation between a decrease in propionate and 
butyrate concentrations in the cecum with increased Salmonella pathology.  
Therefore, in this work, we further characterized the repressive effect of 
propionate and butyrate on SPI 1 invasion using in vitro studies.  We found 
that concentrations of propionate and butyrate comparable to that seen in the 
normal mouse cecum repressed SPI 1 invasion genes and decreased invasion 
of HEp-2 cells.  We also found that the negative effect on invasion genes was 
observed at a pH of 6.7 but not at a pH of 8.0, suggesting that fatty acids must 
enter the bacterial cytoplasm to have the repressive effect.  Additionally, we 
found that it was necessary for propionate to be metabolized for repression of 
invasion and that the metabolic intermediate, propionyl-CoA, is important for 
this effect.  We also found that propionate and butyrate cause a shift in the 
protein expression of flagellin.  Thus, propionate and butyrate affect more than 
one virulence determinant important for intestinal pathogenesis. 
 
INTRODUCTION 
 Salmonella enterica is a major cause of food-borne illness and can 
cause a range of illnesses from self-limiting intestinal disease to septicemia.    
For Salmonella to cause disease, it must first invade the epithelium of the 
intestinal tract.  Invasion of the intestinal tract is mediated by a type three 
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secretion system (TTSS) which is encoded in Salmonella Pathogenicity Island 
1 (SPI 1) (10, 29, 35, 43, 51, 57, 60) .  The TTSS forms a ―needle complex‖ 
(46) which is used to inject effector proteins into the host cell that cause 
changes in the host cell cytoskeleton leading to engulfment of the bacterium 
(reviewed by 28).  The genes encoded in SPI 1 and the invasion process are 
required for both the intestinal and septicemic form of disease (9, 29, 43, 69). 
 SPI 1 genes are controlled by a complex regulatory network of 
transcriptional and post-transcriptional regulators both within and outside SPI 
1.  Regulators within the island are HilA, HilC, HilD, and InvF, with HilA 
characterized as the central regulator.  HilA, a member of the OmpR/ToxR 
family, is an activator that regulates transcription of the following genes in SPI 
1:  the inv/spa operons, the prg/org operons, and the sic/sip operon via the 
read-through transcript of the inv/spa operons (7, 18, 52).  InvF is also a 
transcriptional regulator of the AraC family (45).  HilA is responsible for 
controlling gene expression of the TTSS apparatus, InvF is responsible for 
controlling secreted effectors outside of SPI 1, and together they control 
secreted effectors within SPI 1 (18, 23).  InvF can be regulated by 
mechanisms independent of HilA, as well (3, 4, 59).  HilA is controlled by HilC 
and HilD from within the island and RtsA and HilE outside SPI 1 (24).  Also, a 
recent study has shown that by an unknown mechanism, HilA can negatively 
regulate itself (20).   
Several regulators encoded outside of SPI 1 have been identified as 
important for control of HilA and InvF, among them are PhoP/PhoQ, 
BarA/SirA, and the Csr system.  PhoP/PhoQ has been shown to negatively 
regulate invasion genes through HilA (8).  This negative regulation is induced 
by low magnesium concentrations (63).  The csr system both positively and 
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negatively regulates SPI 1 invasion gene expression through changes in the 
level of CsrA (3).  In Salmonella it consists of a small protein CsrA, and two 
untranslated RNAs, CsrB and CsrC, that control the level of CsrA (3, 26).  The 
BarA/SirA regulatory system positively regulates invasion gene expression.  
BarA is a sensor kinase of the phosphorelay type, and SirA is its response 
regulator (4, 66).  BarA/SirA induce invasion gene expression through their 
effect on expression of CsrB and CsrC (26, 49).  It is thought that BarA/SirA 
induce expression of CsrB and CsrC, decreasing the levels of free CsrA ,and 
inducing invasion gene expression (2). 
Environmental factors mediate invasion gene expression through 
regulation of hilA expression (8).  The conditions that positively regulate SPI 1 
gene expression are  low oxygen, log phase growth, high osmolarity, changes 
in DNA supercoiling, and slightly alkaline pH (8, 25, 30, 50, 61).  It has also 
been shown that short chain fatty acids are important for both positive and 
negative regulation of invasion gene expression.   Acetate and formate act as 
cytoplasmic signals to induce invasion gene expression, however acetate 
requires SirA for this effect, whereas formate does not (41, 49).  For both of 
these fatty acids, the effects are observed at pH 6.7 but abrogated at pH 8.0, 
suggesting that the fatty acids must concentrate in the bacterial cytoplasm to 
have their effect (41, 49).   In contrast, butyrate and propionate have been 
shown to repress invasion genes (12, 31, 49).   
Studies have been performed to characterize the intestinal 
environment, and many of the environmental conditions listed above can be 
found in the intestinal tract.  In particular, in various mammalian species, 
studies show that acetate, propionate, and butyrate are found in both the 
cecum and the colon, and that acetate, propionate, and formate have been 
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found in the ileum (5, 11, 16, 32, 47, 48, 55).  Also, the pH throughout the 
distal ileum, cecum, and proximal colon is between 6.0 and 7.0 (6, 11, 32).  
The conditions in the ileum, the area previously described as the location for 
invasion (14, 44), are conditions known to induce invasion genes (41, 49), 
whereas the conditions of the cecum and colon may be more likely to repress 
invasion genes (49).  Therefore, it seems likely that these conditions in the 
intestinal tract are signals for Salmonella, indicating a location for productive 
invasion.  In fact, more than one in vivo study in mice has shown a correlation 
between a decrease in short chain fatty acid concentrations and increased 
susceptibility to Salmonella infection (32, 68). 
Another determinant important to Salmonella virulence is the regulated 
expression of flagella.  More specifically, flagellin has previously been shown 
to activate the host immune response (34).  In Salmonella, there are two 
genes that encode flagellin, fliC and fljB.  These two subunits are not 
expressed at the same time because of a mechanism called phase variation.  
Control of phase variation is achieved through the regulator FljA, with fljA 
being expressed as part of an operon with fljB (62).  When this operon is 
expressed type 2 flagellin is produced, and FljA production negatively 
regulates fliC , preventing expression of type 1 flagellin (1, 70).    Previous 
work has examined the importance of FliC in the mouse model of infection, 
finding that fliC expression occurred primarily in the Peyer’s patches (17)  and 
that it was important for induction of the host inflammatory response (reviewed 
by34).  Additionally, a previous study observed a decrease in fliC expression 
under conditions that represent intracellular conditions (17).  Thus, as flagellin 
is important for the host immune response, it is possible that the environment 
of the host may affect which flagellin subunit is expressed. 
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 In this work, we examined the repressive effects of propionic acid and 
butyric acid at the level of gene expression, secreted protein expression, and 
epithelial cell invasion and found that both fatty acids repressed invasion and 
that pH was important for the repressive effect.  Additionally, as the pathways 
for propionate metabolism have previously been characterized in Salmonella, 
we further examined the repressive effect of propionic acid to understand the 
mechanism by which it affects invasion.  We show here that metabolism of 
propionic acid is necessary for its repressive effect and that in particular the 
metabolic intermediate propionyl- CoA is important for this effect.  Additionally, 
we found that propionic acid and butyric acid in the wild type caused a switch 
in the phase variation of flagellin present. 
 
MATERIALS AND METHODS 
Bacterial Strains.  Bacterial strains and plasmids used in this study can be 
found in Table 1.  All strains were isogenic to Salmonella enterica serovar 
Typhimurium strain ATCC 14028s.  All gene deletions were created using a 
previously described one-step inactivation method (19).  The chloramphenicol 
and kanamycin markers from pKD3 and pKD4 respectively were used.  
Primers at the 5’ end included 40 bp of homology to the region surrounding the 
start and stop codon of the gene to be deleted and the 3’ end of the primers 
contained sequence homologous to the plasmids.  The resultant PCR product 
was then transformed into Salmonella enterica serovar Typhimurium strain 
ATCC 14028s containing the pKD46 plasmid which contains the λ Red 
recombinase which allows for allelic exchange.  All deletion mutants were 
checked for the loss of the gene using PCR.  P22 transduction was used to 
move marked deletions to create multiple mutations in one strain.  Also, when  
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necessary for strains with multiple mutations or where there might be a 
question of polarity, the FLP recombinase was used to remove markers (19).  
Table 1.  Strains and plasmids used in this study. 
 
 
Strain or 
plasmid 
 
Genotype 
 
Source or reference 
Strains   
   ATCC 14028s Wild type American Type 
Culture Collection 
   CA412 sipC::lacZY 8 
   CA1272 ΔackA This study 
   CA1274 sipC::lacZY ΔackA This study 
   CA1828 sipC::lacZY ΔackA, tdcD This study 
   CA1857 sipC::lacZY ΔackA, tdcD, pduW This study 
   CA1861 sipC::lacZY ΔackA, tdcD, pduW, prpE, acs This study 
   CA1831 sipC::lacZY ΔackA, tdcD, pduW, pta This study 
   CA1872 sipC::lacZY ΔprpE, acs This study 
   CA1889 ΔackA, tdcD, pduW This study 
   CA1512 sipC::lacZY ΔprpC This study 
   CA1796 sipC::lacZY Δacs, prpE, pta This study 
   CA1821 sipC::lacZY Δacs, prpE, pta, pflB, tdcE This study 
Plasmid   
   pCAYC177 vector only control 15 
   pCA171 ackA ORF on pCAYC177 This study 
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The complementation plasmid was created by amplifying the ackA open 
reading frame (ORF) including enough upstream sequence to include the 
ribosome binding site.  The PCR product was then cloned into the kanamycin 
gene in the cloning vector pACYC177.  
β-galactosidase assays.  Cultures were grown overnight standing at 37°C in 
LB/100 mM MOPS pH 6.7 containing either no additive, 10 mM propionic acid, 
or 10 mM butyric acid.  For experiments where a pH of 8.0 was necessary, 
100 mM HEPES pH 8.0 was used in place of the MOPS.  All cultures were 
grown in triplicate and β-galactosidase activity was measured as previously 
described (56). 
HEp-2 invasion assays.  The invasion assay was performed as previously 
described (4), except for upon infection plates were centrifuged at 100 x g.  
Also, for this assay, cultures were grown overnight standing at 37°C in LB/100 
mM MOPS pH 6.7 with no additive, 10 mM propionic acid, or 10 mM butyric 
acid.  Quadruplicates were tested for each strain in each condition. 
Analysis of secreted proteins.  Secreted proteins were isolated and 
analyzed as previously described (4), with the exception that cultures were 
grown in LB/100 mM MOPS pH 6.7, with either no additive, 10 mM propionic 
acid, or 10 mM butyric acid.  To identify unknown proteins, bands were cut 
from the gel and submitted to the Cornell University Proteomics and Mass 
Spectrometry Core Facility for matrix-assisted laser desorption ionization-time-
of-flight mass spectrometry (MALDI-TOF) analysis. 
Statistical Analysis.  Results from β-galactosidase assays and invasion 
assays was analyzed using a one-way analysis of variance to determine if the 
mean of at least one strain or condition differed from any of the others.  The 
Tukey-Kramer HSD multiple comparison test was then used to determine 
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which means were statistically different.  A p-value <0.05 was considered 
significant.   Statistical analysis was performed using Jmp 8.0 software (SAS, 
Cary, NC). 
 
RESULTS 
Propionate and butyrate repress SPI 1 invasion gene expression.  Fatty 
acids are the predominant metabolic product of the anaerobic intestinal 
microbiota and so largely define the environment of the mammalian intestinal 
tract.  Previous work in our lab showed that propionate and butyrate, major 
constituents of the large intestine, reduced SPI 1 invasion gene expression in 
vitro when supplied at physiologically relevant concentrations (32, 49).  
Therefore, we sought to understand how these fatty acids repress invasion 
genes.  In vitro studies of the effects of these fatty acids on invasion genes 
have used varying concentrations of the fatty acids (12, 21, 31, 49).  However, 
our recent in vivo work using a mouse model of infection showed the median 
propionate and butyrate concentrations in the cecum to be 8.5 mM and 12.8 
mM respectively (32);  therefore, for this work we proceeded with 10mM 
concentrations of the fatty acids.  Using media buffered to pH 6.7 and 10 mM 
concentrations of either propionic acid or butyric acid, we used lacZY reporter 
fusions to the SPI 1 invasion genes, sipC, encoding a secreted effector 
protein, and hilA and invF, both transcriptional regulators.  Using these strains, 
we found that there was a significant decrease in gene expression for each, 
more than 8-fold for sipC and 5-fold each for invF and hilA, in the presence of 
either propionic acid or butyric acid (Fig. 3.1 and data not shown).  
Additionally, previous work in our lab has shown that pH is important for the  
 
   
79 
 
Figure 3.1. Propionate and butyrate repress sipC invasion gene 
expression.  Cultures of wild type with the sipC::lacZY reporter fusion were 
grown overnight standing in LB with either 100 mM MOPS pH 6.7 or 100 mM 
HEPES pH 8.0, containing no additive (black bars), 10 mM propionic acid 
(striped bars), or 10 mM butyric acid (white bars).  β-galactosidase assays 
were used to assess sipC expression.  An asterisk (*) indicates a statistically 
significant difference from wild type with no additive at p < 0.01. 
 
 
effects of acetate and formate on invasion gene expression, suggesting that 
accumulation of the fatty acid in the bacterial cytoplasm was necessary for the  
observed effects (41, 49).  Thus, we also examined whether pH, and by 
extension, the ability of the fatty acid to enter the cytoplasm was necessary for 
the repressive effects of propionate and butyrate.  In contrast to the repression 
observed when the medium was maintained at pH 6.7, using a pH of 8.0 we 
found that propionate and butyrate failed to have repressive effects on sipC, 
invF, or hilA.   Instead, there was a slight increase in expression in the 
presence of propionate (Fig. 3.1 and not shown).  Thus, these results show 
that pH is important for the repressive effects of propionate and butyrate and 
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suggest that theses fatty acids must enter the bacterial cytoplasm to have their 
negative effects.   
Since SPI 1 invasion genes are repressed in the presence of 
propionate and butyrate, we next examined whether these fatty acids had any 
effect on invasion of epithelial cells in vitro.   Using wild type Salmonella grown 
overnight in media buffered to pH 6.7 with either no additive, 10 mM propionic 
acid, or 10 mM butyric acid, we found that propionic acid and butyric acid 
significantly decreased invasion of HEp-2 cells, by 2-fold and 5-fold, 
respectively (Fig 3.2).  Therefore, these results, consistent with those of other 
studies (12, 22, 67), confirm that propionate and butyrate not only affect 
expression of invasion genes, but also decrease invasion of epithelial cells. 
 
 
Figure 3.2. Propionate and butyrate significantly decrease invasion of 
HEp-2 cells in wild type but not in an ackA, tdcD, pduW mutant.  Strains 
were grown overnight standing in LB with 100 mM MOPS pH 6.7 containing 
either no additive (black bars), 10 mM propionic acid (striped bars), or 10 mM 
butyric acid (white bars).  Invasion of HEp-2 cells was assessed using a 
gentamicin protection assay.  Invasion of all strains and the various conditions 
are shown relative to wild type invasion in no additive which was set to 100%.   
An asterisk (*) indicates a statistically significant difference from wild type with 
no additive at p < 0.01.  Two asterisks (**) indicates a statistically significant 
difference from wild type with propionate or butyrate p < 0.01. 
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Metabolism of propionate is necessary for its repressive effect on SPI 1 
invasion genes. As pH and the ability of propionate and butyrate to enter the 
bacterial cytoplasm were important for their repressive effects on SPI 1 
invasion genes, we next asked whether the fatty acids acted directly on 
invasion genes or whether they must be first converted to a metabolic product 
to have an effect.  In enteric organisms, little is known about the metabolism of 
butyrate; however, the pathways for propionate metabolism have been well-
characterized in Salmonella and E. coli (36-40, 58)(Fig 3.3).   
 
 
Figure 3.3. Diagram of known pathways and genes required for 
propionate metabolism 
 
 
Therefore, we examined the genes in the propionate metabolic pathways to 
determine whether they were important for the repressive effects of propionate 
on SPI 1 invasion.  There are two characterized pathways for the initial steps 
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of propionate metabolism, the propionate-kinase phosphotransacetylase 
pathway and the acyl CoA synthetase pathway, that both lead to the  
intermediate propionyl-CoA which then feeds into the methyl citric acid cycle 
(58). The propionate-kinase phosphotransacetylase pathway utilizes three 
genes, ackA which is an acetate kinase, and tdcD and pduW which are 
propionate kinases, that first metabolize propionic acid to propionyl phosphate 
(58).  The propionyl phosphate is then metabolized to propionyl-CoA by a 
phosphotransacetylase encoded by pta, which is expressed in an operon with 
ackA (58).  The acyl CoA synthetase pathway metabolizes propionate directly 
to propionyl-CoA without the propionyl phosphate intermediate, using two 
additional genes, acs and prpE, which encode acetyl CoA and propionyl-CoA 
synthetases (39).  To determine whether metabolism of propionate was 
important for its repressive effect on invasion, we first examined the 
propionate-kinase phosphotransacetylase pathway.  Using the sipC::lacZY 
reporter strain, we tested a non-polar null mutant of ackA and found that the 
mutation prevented the repression of sipC normally seen in the presence of 
propionate.  There was a significant, nearly 4-fold, increase in gene 
expression when compared to wild type in the presence of propionic acid, and 
the mutation restored invasion gene expression to the level seen in the mutant 
with no additive (Fig. 3.4A).  Additionally, the effect seen was specific for 
propionic acid, because invasion gene expression in the presence of butyrate 
was significantly increased but never reached the complete restoration 
observed with propionic acid (Fig. 3.4A).  Thus, these results demonstrate that 
metabolism of propionate is necessary for the repressive effect on invasion 
genes.   
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Figure 3.4. Metabolism of propionate is necessary for its repressive 
effect on invasion gene expression.  Wild type and mutant strains with the 
sipC::lacZY reporter fusion were grown overnight standing in LB with 100 mM 
MOPS pH 6.7 containing either no additive (black bars), 10 mM propionic acid 
(striped bars), or 10 mM butyric acid (white bars).  β-galactosidase assays 
were used to assess sipC expression.  A) Mutants containing deletions of 
genes in the propionate-kinase phosphotransacetylase pathway, B) Mutant 
containing deletions of the genes in the acyl CoA synthetase pathway and a 
mutant containing deletions of genes in both pathways.  An asterisk (*) 
indicates a statistically significant difference from each respective strain with 
propionate or butyrate compared to no additive at p < 0.01.  Two asterisks (**) 
indicates a statistically significant difference of a mutant strain grown in 
propionate compared to wild type with propionate or mutant strain grown in 
butyrate compared to wild type with butyrate at p < 0.01. 
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Although the loss of ackA appeared to prevent the repression of sipC 
expression by propionate, and this mutant was designed to be non-polar, ackA 
resides immediately upstream from pta in an operon.  To determine whether  
the observed phenotype could be attributed solely to ackA, we created a 
complementation plasmid containing the ackA ORF and tested this plasmid in 
the ackA mutant containing the sipC::lacZY fusion.  As expected, the ackA 
mutation with and without the pACYC177 cloning vector in the sipC::lacZY 
background restored invasion gene expression in the presence of propionic 
acid (Fig. 3.5).   
 
 
Figure 3.5. Complementation with ackA restores repression of invasion 
genes in the presence of propionate.  A complementation plasmid 
containing the ackA ORF was created (pCA171) and it and the vector only 
control (pACYC177) were moved separately into the ackA mutant.  These 
strains were tested along with the ackA mutant and wild type.  All strains had 
the sipC::lacZY reporter fusion and were grown overnight standing in LB with 
100 mM MOPS pH 6.7 containing either no additive (black bars), 10 mM 
propionic acid (striped bars), or 10 mM butyric acid (white bars).  β-
galactosidase assays were used to assess sipC expression.  An asterisk (*) 
indicates a statistically significant difference from each respective strain with 
propionate or butyrate compared to no additive at p < 0.01.  Two asterisks (**) 
indicates a statistically significant difference of a mutant strain grown in 
propionate compared to wild type with propionate or mutant strain grown in 
butyrate compared to wild type with butyrate at p < 0.01. 
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The levels of expression observed in this figure for the mutant with no additive, 
with propionate, and with butyrate are slightly higher than that seen in Fig. 
3.4A showing some variation in the results, however, even with the variation 
observed there is still a significant increase with butyrate and the complete 
restoration of gene expression in the presence of propionate in the ackA 
mutant as previously seen.  Upon addition of the complementation plasmid 
containing the ackA ORF, however, we found that the repressive effects of 
propionic acid were restored (Fig. 3.5).  These results thus show that ackA is 
necessary and sufficient for the negative effect of propionic acid. 
As there are two additional genes, tdcD and pduW, that encode 
proteins that can metabolize propionic acid to propionyl phosphate, we next 
asked whether they were also important for the repressive effect of propionic 
acid.  The increase in invasion gene expression with the double or triple 
mutant when compared to the single mutant was not statistically significant 
(Fig. 3.4A), and so these genes had slight additive effects on the restoration of 
expression in the presence of propionic acid at best.  However, in contrast to 
the results seen at the level of gene expression, we found using a HEp-2 
invasion assay, that invasion in the ackA, tdcD, pduW mutant was not only 
restored in the presence of propionic acid, but, in fact, was increased 10-fold 
when compared to the wild type with propionic acid and 5-fold when compared 
to the wild type with no additive (Fig. 3.2).  These results show that 
metabolism of propionate is necessary for the repressive effect on invasion 
and suggest that propionate itself may affect other factors important for cell 
invasion in addition to the effect observed on invasion gene expression in 
vitro. 
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   As we had shown that the acetate/propionate-kinase genes were 
important for the repressive effect of propionate on SPI 1 invasion genes, we 
next asked whether the genes in the acyl CoA synthetase pathway of 
propionate metabolism were necessary as well.  We found that the loss of this 
pathway through null mutations in both necessary genes, acs and prpE (Fig. 
3.3), did not alter the negative effect of propionic acid on invasion genes (Fig. 
3.4B).   To further address this question, we also examined the effects of 
deleting all the known genes necessary for propionate metabolism, ackA, 
tdcD, pduW, acs, and prpE, and found there was not a significant increase in 
restoration when compared with the ackA single mutant, the ackA, tdcD 
double, or the ackA, tdcD, pduW triple mutants (Fig. 3.4).  These results thus 
show that the metabolic pathway leading through propionyl phosphate is the 
important pathway for the effects on SPI 1 invasion genes. 
Propionyl phosphate is not the important intermediate for the repressive 
effect of propionate.  SPI 1 invasion gene expression was restored in the 
ackA, tdcD, pduW mutant in the presence of propionic acid, suggesting that 
the metabolic intermediate created by these protein products, propionyl 
phosphate, might be important for this negative effect.    To determine the 
importance of propionyl phosphate for the repressive effect of propionate, we 
examined invasion gene expression using a strain with all the known pathways 
to propionyl phosphate deleted (Fig. 3.3), an ackA, tdcD, pduW, pta mutant, 
using a sipC::lacZY fusion.  If propionyl phosphate negatively affected invasion 
genes, this strain would be expected to have a phenotype identical to that of 
the ackA, tdcD, pduW mutant.  Surprisingly, we found that in the presence of 
propionic acid invasion gene expression in the ackA, tdcD, pduW, pta mutant 
was significantly lower than in the ackA, tdcD, pduW mutant under the same 
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conditions and also lower than in the ackA, tdcD, pduW, pta  without the 
addition of propionic acid.  Furthermore, invasion gene expression in this 
strain was not significantly higher than wild type with propionic acid (Fig. 3.4A).  
Thus, the addition of the pta mutation restored the repressive effect of 
propionate on invasion genes, demonstrating that propionyl phosphate is not 
the important intermediate for the negative effect on invasion genes. 
The intermediate propionyl-CoA is important for the repressive effect of 
propionate on SPI 1 invasion.  Previous work suggests that entry into the 2-
methyl citric acid cycle and the intermediate 2-methyl-citrate are important for 
the toxic effects of propionate on growth of Salmonella (37) (Fig. 3.3).  
Therefore, we hypothesized that this might also be the case for its effect on 
SPI 1 invasion gene expression.  Entry into the 2-methyl citric acid cycle, as 
well as production of 2-methyl citrate, requires the gene prpC (40).  
Additionally, gltA has been proposed to play a lesser role to prpC in the 
production of 2-methyl citrate from propionyl-CoA (37).  To test our hypothesis, 
we examined null mutations of prpC and gltA alone, and prpC and gltA 
together using the sipC::lacZY fusion strain.  We found that invasion gene 
expression in the presence of propionic acid was the same as that seen in wild 
type for all three strains (Fig. 3.6 and not shown).  To further confirm that the 
2-methyl citric acid cycle and 2-methyl-citrate production were not necessary 
for the repressive effect of propionate on invasion gene expression, we also 
examined a null mutation of prpD, the next gene in the cycle, required for 
conversion of 2-methyl citrate to 2-methyl-cis-aconitate (38).  However, once 
more, invasion gene expression was the same in the prpD mutant as in wild 
type (not shown).  Thus, these results show that neither entry into the 2-methyl  
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Figure 3.6. Production of the intermediate propionyl-CoA is important for 
the repressive effect of propionate.  Wild type and mutant strains with the 
sipC::lacZY reporter fusion were grown overnight standing in LB with 100 mM 
MOPS pH 6.7 containing either no additive (black bars), 10 mM propionic acid 
(striped bars), or 10 mM butyric acid (white bars).  β-galactosidase assays 
were used to assess sipC expression.    An asterisk (*) indicates a statistically 
significant difference from each respective strain with propionate or butyrate 
compared to no additive at p < 0.01.  Two asterisks (**) indicates a statistically 
significant difference of a mutant strain grown in propionate compared to wild 
type with propionate or mutant strain grown in butyrate compared to wild type 
with butyrate at p < 0.01. 
 
 
citric acid cycle nor the intermediate 2-methyl-citrate is required for the 
repressive effect of propionate. 
Since propionyl phosphate and the 2-methyl citric acid cycle were not 
important for the repressive effect of propionate on invasion genes, we 
hypothesized that propionyl-CoA may be important for the negative effect of 
propionate.  Propionyl-CoA is an intermediate in the propionate metabolic 
pathway and can be produced from propionate directly by the products of the 
genes acs and prpE, or indirectly from propionyl phosphate through pta  (39, 
58) (Fig. 3.3).  Therefore, to address the question of whether propionyl-CoA 
production was important for the negative effect of propionate, we next created 
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null mutants of prpE, acs, and pta in the sipC::lacZY fusion strain.  Using this 
strain, we found a 2-fold increase in invasion gene expression in the presence 
of propionic acid when compared to wild type with propionic acid (Fig. 3.6).  
However, there are previous reports that tdcE and pfl can produce propionyl-
CoA from endogenous sources (36).  Thus, we created a mutant that deleted 
all known pathways for the production of propionyl-CoA from endogenous and 
exogenous sources (a prpE, acs, pta, pflB, tdcE mutant).  We found that 
invasion gene expression was increased 3-fold from the wild type level in the 
presence of propionic acid (Fig. 3.6).  Additionally, for both the prpE, acs, pta 
mutant and the prpE, acs, pta, pflB, tdcE mutant, the increase in invasion gene 
expression seen in the presence of propionic acid was specific for propionic 
acid, as the same effect was not observed with butyric acid.  Therefore, these 
results suggest that production of propionyl-CoA from propionate is necessary 
for the negative effect of propionate. 
Effect of propionic acid and butyric acid on phase variation of flagellin.  
SPI 1 not only encodes genes necessary to produce a type three secretion  
system (TTSS), it also encodes several of the effector proteins secreted by the 
TTSS (53). Thus, since propionate and butyrate repressed SPI 1 invasion 
gene expression, we hypothesized that it would also decrease the expression 
of the secreted effector proteins.  To test this hypothesis we examined 
secreted proteins of Salmonella grown in media buffered to pH 6.7 with either:  
no additive, 10 mM propionic acid, or 10 mM butyric acid.  Using an SDS 
PAGE we found that propionate and butyrate mildly decreased the secreted 
effector proteins, but more interestingly, there were changes in two unknown 
proteins upon treatment with either fatty acid (Fig. 3.7).  One protein found just 
below 50 kDa was heavy in wild type with no additive, however, upon  
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Figure 3.7. Effect of propionate and butyrate on secreted proteins.  Wild 
type and mutant strains were grown overnight in LB with 100 mM MOPS pH 
6.7 containing either no additive, 10 mM propionic acid, or 10 mM butyric acid. 
Secreted proteins were isolated and separated by 10% SDS PAGE.  Strains 
are listed on the horizontal axis above the gel and growth conditions are 
shown on the horizontal axis below the gel.  Molecular weights in kDa are 
shown along the left vertical axis of the gel. 
 
 
treatment with either 10 mM propionic acid or 10 mM butyric acid the intensity 
of this band was decreased and a distinct band appeared just above 50 kDa.  
To determine the identity of the proteins represented by these bands, MALDI-
TOF analysis was utilized.  Upon comparison of the sequence obtained by 
MALDI-TOF, we found that proteins of both molecular weights were flagellin.  
The protein with the apparent molecular weight of 56 kDa in the samples 
treated with fatty acids was identified as type 2 flagellin, encoded in 
Salmonella by fljB, while the protein with an apparent molecular weight of 52 
kDa, more abundant in cultures with no additive, was identified as type 1 
flagellin, encoded by fliC.  Therefore, these results suggest that these fatty 
acids may cause a change in flagellar phase variation between type 1 and 
type 2 flagellin. 
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DISCUSSION 
For Salmonella to cause disease it must first invade the intestinal 
epithelium and to do so it requires genes encoded in SPI 1.  In this work, we 
show that propionic acid and butyric acid, at a pH and with concentrations 
comparable to those seen in the murine intestinal tract (32), repress SPI 1 
invasion genes and reduce invasion of epithelial cells.  These results are 
consistent with previous studies examining varying concentrations of these 
fatty acids as well as various pH levels (12, 22, 31, 67).  Therefore, we sought 
to further understand the mechanism by which these fatty acids repress 
invasion and since little was known about butyric acid metabolism in 
Salmonella, we concentrated on characterizing the effect of propionic acid.   
We found that deletion of the genes necessary for production of the propionyl 
phosphate intermediate from propionate restored invasion gene expression in 
the presence of propionate whereas deletion of the genes necessary for 
directly metabolizing propionate to propionyl-CoA did not.  These results thus 
implicated two intermediates of propionate metabolism, propionyl phosphate 
and propionyl-CoA, as possibly important for the repressive effect of 
propionate.  Upon deletion of pta, the phosphotransacetylase that can 
reversibly interconvert propionyl phosphate and propionyl-CoA, however, the 
restoration of invasion gene expression was abrogated.  One possible 
explanation for these results is that for metabolism of propionate in the 
conditions used for this study, the propionyl-kinase phosphotransacetylase 
pathway is the major route for propionate metabolism.  Therefore, when this 
pathway is no longer present, propionyl phosphate is not being produced by 
the normal pathway.  However, the bacterium may use the acyl-CoA 
synthetase pathway alternatively to metabolize propionate.  When this occurs, 
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since propionyl phosphate is not being produced by its normal pathway, it is 
possible that the pta gene may utilize propionyl-CoA for production of 
propionyl phosphate thus decreasing the repressive effect of propionyl-CoA.  
However, when pta is deleted, propionyl-CoA may accumulate due to the loss 
of the pathways by which it is metabolized, causing the repressive effect on 
invasion gene expression.  Further evidence for the involvement of propionyl-
CoA in repression of invasion gene expression is the fact that upon deletion of 
the genes necessary for metabolism of exogenous propionate, there is a two-
fold increase in invasion gene expression in the presence of propionate when 
compared to wild type in the presence of propionate.  Also, a mutant that has 
genes deleted in the known pathways for production of propionyl-CoA from 
both endogenous and exogenous sources, a prpE, acs, pta, pflB, tdcE mutant, 
has a 3-fold increase in invasion gene expression in the presence of 
propionate when compared to wild type with propionate.  However, there is not 
full restoration in either of these mutants, suggesting that there may be an as 
yet uncharacterized propionyl synthetase enzyme that is able to metabolize 
propionate to propionyl-CoA, thus preventing complete restoration of invasion 
gene expression.  Further evidence to support this hypothesis is that a mutant 
that blocks the known pathways of propionate metabolism (ackA, tdcD, pduW, 
acs, prpE) has restored invasion gene expression in the presence of 
propionate (Fig. 3.4B). However, further mutation of pta in this mutant restores 
repression of invasion gene expression (not shown), suggesting that 
propionyl-CoA can still be produced from propionate in this strain.  
Additionally, if entrance into the 2-methyl citric acid cycle is blocked, propionic 
acid still has a repressive effect on invasion genes, suggesting that propionyl-
CoA or some derivative of it is responsible for the observed effect. 
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Therefore, we next asked how propionyl-CoA could have this negative 
effect on invasion genes.  One possible model of how propionyl-CoA 
represses invasion is by the inactivation of proteins through the addition of a 
propionyl moiety donated by propionyl-CoA.  Propionyl-CoA has previously 
been reported to inactivate PrpE via N-Lysine propionylation (33).  For this to 
occur, Pat (Protein Acetyltransferase) transfers a propionyl group from 
propionyl-CoA to a lysine residue on PrpE, which contains the motif 
PXXXXGK, thus inactivating the protein (33, 64).  Therefore, we hypothesized 
that propionyl-CoA might repress invasion genes by protein inactivation.  
Previous work has shown that the Fad system, involved in long chain fatty acid 
oxidation, regulates invasion genes in Salmonella (54).  FadD is an acyl CoA 
synthetase that is also necessary for transport of long chain fatty acids into the 
cell and FadR is a transcriptional regulator of the fad (fatty acid degradation) 
and fab (fatty acid biosynthesis) genes (27).  Additionally FadK has recently 
been identified as an anaerobic acyl CoA synthetase (13).   Upon examining 
the protein sequence of both FadD and FadK, we found that both had the 
PXXXXGK motif important for propionylation.  Thus, we examined a pat 
mutant, single mutants of fadD, fadK, and fadR, and double mutants of 
fadD,fadK and fadD,fadR in the  presence of propionic acid and found that 
invasion gene expression was still repressed in all the strains (not shown).  
Therefore, from these results we concluded that propionylation by pat was not 
important for the repressive effect of propionate on invasion genes nor were 
proteins known to be required for fatty acid transport.  There still remains the 
possibility however, that propionyl-CoA exerts its repressive effect by 
modification of other, uncharacterized proteins.   
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Although our results suggest that propionate must be metabolized to 
propionyl-CoA to have the observed repressive effect on invasion genes, one 
other possible model to explain our results that cannot be completely ruled out 
is that it is acetyl-CoA rather than propionyl-CoA that is responsible for the 
negative effect on invasion genes.  Many of the genes necessary for 
propionate metabolism are also involved in acetate metabolism.  Acetate 
kinase, the product of ackA can reversibly interconvert acetate to acetyl 
phosphate, while phosphotransacetylase, encoded by pta, reversibly 
interconverts acetyl phosphate to acetyl-CoA.   Acetyl-CoA synthetase, 
encoded by acs, can metabolize acetate directly to acetyl-CoA (65).  Thus, it is 
possible that the effect we observe in our deletion mutant of ackA could be a 
result of changes in the metabolism of acetyl-CoA to acetyl phosphate.  
However, if the effect we observe was a result of changes in acetate 
metabolism, it would be expected that the same effect would be observed with 
acetate as seen with propionate; previous results show that this is not the case 
(49).  Also, the only known pathway for metabolism of propionate to acetyl-
CoA is through the 2-methyl citric acid cycle.   The results in this paper show 
that deletion of prpC, the gene necessary for entry into the 2-methyl citric acid 
cycle, does not affect the repressive effect of propionate on invasion genes.  
Thus, though we cannot completely rule out this model, our results suggest 
that propionyl-CoA, and not acetyl-CoA, is the important metabolic 
intermediate.     
 Using a HEp-2 invasion assay, we also found that propionate 
significantly decreased invasion of epithelial cells consistent with the results 
observed for invasion gene expression.  For invasion genes, we had found 
that metabolism of propionate was important for the repressive effect, with 
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invasion gene expression restored in the presence of propionic acid for an 
ackA, tdcD, pduW deletion mutant.  Thus, we examined this same mutant 
using a HEp-2 invasion assay and found that in the presence of propionic acid 
that invasion was not only restored to the level of wild type without propionic 
acid but was actually increased 5-fold and that in the presence of butyric acid 
that invasion was restored to the level of wild type.  These results were 
surprising as the same level of increase was not observed in the assays 
examining invasion gene expression; however, the invasion assay measures 
more than just invasion genes.  In Salmonella, the invasion process is 
complex involving multiple virulence factors (42), so it is possible that 
propionate affects other factors important for invasion.  In fact, data suggest 
that propionate affects flagellin production and motility (not shown) as well.  
Thus, it is possible that the increase in invasion is a result of the effect on 
invasion genes in combination with one or more other virulence factors. 
In this work, we also found that propionate and butyrate caused 
changes in flagellin expression.  In Salmonella, there are two genes, fliC and 
fljB, that encode flagellin and they are not expressed at the same time as a 
result of phase variation.  In this work, we found that there was a shift from 
type 1 flagellin (encoded by fliC) to type 2 flagellin (encoded by fljB) in the 
presence of both propionate and butyrate.  These results suggest that 
environmental conditions may be important for determining which type of 
flagellin is expressed.  Consistent with these results, previous work examining 
fliC expression found that fliC expression is decreased under in vitro 
conditions resembling the intracellular environment whereas expression is 
present in the Peyer’s Patches of mice in vivo (17).  Therefore, these results 
suggest that the bacterium may use phase variation to alter its flagellin 
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expression in response to environmental signals in the intestinal tract.  
However, further work is necessary to characterize this phenomenon. 
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CHAPTER 4 
Molecular identification of veterinary yeast isolates using sequence-
based analysis of the D1/D2 region of the large ribosomal subunit* 
 
 
 
 
 
 
 
 
 
 
 
*Garner, C.D., Starr, J.K., McDonough, P.L., and Altier, C.  Molecular 
identification of veterinary yeast isolates using sequence-based analysis of the 
D1/D2 region of the large ribosomal subunit.  Submitted to the Journal of 
Clinical Microbiology. 
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ABSTRACT 
Conventional methods of yeast identification are often time-consuming and 
difficult; however, recent studies of sequence-based identification methods 
have shown promise.  Additionally, little is known about the diversity of yeast 
identified from various animal species in veterinary diagnostic laboratories.  
Therefore, in this study, we examined three methods of identification using 
109 yeast isolated during a one year period from veterinary clinical samples.  
Comparison of the three methods, traditional substrate assimilation, fatty acid 
profile analysis, and sequence-based analysis of the D1/D2 region of the large 
ribosomal subunit showed that sequence analysis provided the highest 
percent identification among the three.  Sequence analysis identified 87% of 
isolates to the species level whereas substrate assimilation and fatty acid 
profile analysis identified only 52% and 47% respectively.  Less stringent 
criteria for identification increased the percent of isolates identified with each 
method to 98% for sequence analysis, 61% for substrate assimilation, and 
55% for fatty acid profile analysis.  We also found that sequence analysis of 
the ITS2 region provided further identification for 36% of yeast not identified to 
the species level by D1/D2 sequence analysis.  Additionally, we identified a 
large variety of yeast from animal sources, with at least 30 different species 
among the isolates tested, and with the majority not belonging to the common 
Candida sp. such as C. albicans, C. glabrata, C. tropicalis, and C. parapsilosis 
group.   Thus, we determined that sequence analysis of the D1/D2 region was 
the best method for identification of the variety of yeast found in a veterinary 
population.   
   
109 
INTRODUCTION 
In both veterinary and human diagnostic laboratories, correct 
identification of yeasts is important for the care of patients.  Traditionally, yeast 
identification has been performed using biochemical analysis, substrate 
assimilation methods, morphological examination, or by various combinations 
of the three.  To increase the ease of identification, commercial tests have 
been created that use these methods.  For example, the Yeast API 20C AUX 
strip (bioMérieux) primarily uses substrate assimilation, Uni-Yeast-Tek 
(Remel) combines substrate assimilation, biochemicals, and morphology, and 
API Candida (bioMérieux) utilizes biochemical reactions for identification.  
Even with the convenience provided by these methods, identification of yeasts 
by these conventional applications can still be time-consuming and difficult.  In 
addition, considerable variability in the efficacy of  these methods has been 
reported for identification of clinically important yeast (11, reviewed by 12, 
reviewed by 32, 36, 42).  The variation in ability to identify yeast isolates 
correctly can be attributed to the limitations of the databases used for the 
comparison of clinical isolates, as well as the subjectivity involved in 
interpretation of results.  In addition to traditional biochemical and assimilation 
methods, analysis of fatty acids using gas chromatography (GC) has also 
been investigated as a method of yeast identification.  One particular system, 
the Sherlock Microbial Identification System (MIDI), determines the profile of 
fatty acids produced by the yeast and compares that profile to an existing 
database to determine the identification.  This method decreases the 
subjectivity in interpreting the results and decreases turn-around time; 
however, previous studies have reported limitations with the database, as well 
as variability in identification depending upon the growth medium (9, 17, 18).   
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 Recent studies have examined the effectiveness of various molecular 
identification methods for yeast using ribosomal RNA genes, such as 
sequence analysis, multiplex PCR, real-time PCR, microarray technology, 
PCR-based fragment length polymorphisms and restriction fragment length 
polymorphisms (reviewed by 32).  Ribosomal RNA genes are used as the 
targets in these tests because they contain both regions of DNA sequence that 
are conserved among yeast genera and those that vary among species.  For 
yeast, the ribosomal RNA genes consist of the adjacent small subunit, the 
internal transcribed spacer 1 (ITS1), the 5.8S, the internal transcribed spacer 2 
(ITS2), and the large subunit, the last of which includes the D1/D2 region at its 
5’ end (reviewed by 31,  and 32).  Of these regions, the ITS1, ITS2, and the 
D1/D2 region have been shown to be the most useful for species-level 
identification of yeast, as a result of the variability within these regions 
(reviewed by 14, and 32).  In particular, sequence analysis of these regions 
has shown great promise in the practice of clinical mycology, with several 
large-scale studies showing these regions to differentiate clinical yeast isolates 
obtained from humans to the species level (3, 4, 6, 13, 24, 26, 33).  
Advantages of sequencing include increased objectivity of result interpretation, 
shorter turn-around times, and a better characterization of unusual organisms 
as a result of the phylogenetic information that molecular methods provide. 
 In human medicine the species of yeasts cultured from patients is 
limited, with Candida albicans being the predominant species isolated (19, 30).  
In contrast, veterinary yeast isolates can be cultured from a wide variety of 
animal species, allowing for the possibility of more diversity among the isolates 
identified.  Though much work has been performed examining phenotypic and 
genotypic methods of yeast identification from veterinary sources, the majority 
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of these studies have concentrated either on a single species of animal or 
yeast (2, 15, 16, 28, 29).   To our knowledge, there has been only one large-
scale examination of multiple yeast and animal species to assess yeast 
identification (5).  That study used conventional phenotypic tests for 
identification of these organisms; no studies examining sequence-based 
analyses have been performed.   
Therefore, in this work, we examined the variety of yeast seen in a 
veterinary diagnostic laboratory during a one year time period, and determined 
the feasibility and effectiveness of identification by a traditional phenotypic 
method, a method analyzing fatty acid profiles, and a sequence-based 
molecular method.  We found that sequence analysis could provide 
identification to the genus and species level for a much higher percentage of 
the isolates tested than either of the phenotypic methods.  We also found that 
there is great diversity in the yeast identified from veterinary sources, with at 
least 30 different species identified among the 109 isolates tested and only 
48% belonging to the more common Candida sp. such as C. albicans, C. 
parapsilosis group, C. glabrata, and C. tropicalis.  Additionally, seven percent 
of the isolates were identified as Arxula adeninivorans, and this more unusual 
isolate was found only in horses and dolphins. 
 
MATERIALS AND METHODS 
Selection of yeasts and growth conditions.  Yeasts used in this study were 
obtained from the culture of clinical veterinary samples during the year 2007 
by the Animal Health Diagnostic Center of Cornell University.  All isolates that 
could be retrieved as pure cultures from frozen archived stocks were used, 
constituting 91% of the total isolates from that year.  Isolates were plated 
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initially onto Sabouraud Dextrose agar from which an isolated colony was sub-
cultured onto the same medium for 24 hours at 28°C.  Cultures were then 
harvested for the identifications methods described below. 
Identification by nutrient assimilation.  Sufficient quantities of yeasts were 
harvested from agar medium to prepare a suspension in water equivalent to a 
McFarland 2 standard. Then, 100 µl of this suspension was transferred to an 
ampule of API C Medium and samples were inoculated into the cupules of an 
API 20 C AUX test strip (bioMerieux, Durham, NC) and incubated for 72 hours 
at 29°C.  The test strips were visually interpreted at 48 and 72 hours post 
inoculation according to the recommendations of the manufacturer, with each 
strip containing a cupule lacking nutrients to serve as the negative control.  
Positive tests were defined by turbidity greater than that of the control when 
examined at either time point.  As a positive control, all samples were tested in 
conjunction with Candida guilliermondii ATCC 6260.  This test produced a 
numerical profile that was then compared to a database provided by the 
manufacturer (https://apiweb.biomerieux.com).  
Fatty acid-based identification.  Yeast isolates were harvested from the 
second and third quadrants of agar medium to obtain organisms in the log 
phase of growth.  Fatty acid methyl esters were produced and then extracted 
using the protocol recommended by the manufacturer (MIDI, Inc., Newark, 
DE).  Fatty acid analysis was performed using an Agilent Technologies 6890N 
gas chromatograph system.  The Sherlock MIS YEAST28/YSTCLN software 
version 6.0 was used for analysis.  Samples were accompanied by the 
reference strain Candida albicans ATCC 14053 as the positive control, and a 
reagent blank as the negative control.  The system was calibrated using a 
calibration mix supplied by the manufacturer (MIS; MIDI Inc., No. 1200-A 
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Calibration Standards Kit).  This method generated a Similarity Index (SI), with 
an SI of 1.000 indicating complete identity.   
Sequence-based identification.  A small portion of a single yeast colony was 
placed in 5 µl of Lyse and Go reagent (Pierce Protein Research Products, 
Rockford, IL) and placed in the thermocycler using the settings recommended 
by the manufacturer for genomic DNA.  Upon completion, 45 µl of a PCR 
master mix containing 300 nM concentration of each primer was added to the 
Lyse and Go reaction.  For amplification of the D1/D2 region of the large 
ribosomal subunit, primers NL1 and NL4 were used (20) .  For amplification of 
the ITS region, primers ITS5 and ITS4 were used (44).  Samples were then 
placed in the thermocycler using the following settings:  94°C for 2 min, then 
30 cycles of 94°C for 30 sec, 52°C (NL1 and NL4) or 54°C (ITS5 and ITS4) for 
45 sec,  and 72°C for 90 sec, with a final elongation step of 72°C  for 10 min.  
PCR reactions were then visualized using a 1% agarose gel.  PCR products 
were prepared for sequencing using ExoSAP-IT (USB, Cleveland, OH), a 
product which removes remaining primers and dNTPs using a combination of 
Exonuclease I and Shrimp Alkaline Phosphatase.  Sequencing was then 
performed by the Cornell University Sequencing Center using primer Seq-NL1, 
ATCAATAAGCGGAGGAAAAG, or ITS3 (44).  This protocol was used for all 
yeasts in this study, except for one isolate eventually identified as C. 
lusitaniae.  As a result of previously reported polymorphisms in the D1/D2 
region (22), Seq-NL1 did not provide sequence long enough to be used for 
identification, so the NL4 reverse primer was used to sequence this isolate.  
Sequences were then uploaded to the Ribosomal Database Project (RDP) 
Pipeline (8) for sequence editing and quality analysis and were then 
downloaded and further edited manually if necessary. Sequences were then 
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compared to the non-redundant NCBI database using BLASTN, with the 
default settings used to find the most similar sequence and were sorted by the 
E score.  To be considered a good identification to the species level, the 
identification had to meet the following criteria:  i) sequence identity ≥ 99.0%, 
ii) ≥ 1.0% separation from the next closest species, iii) ≥ 90.0% sequence 
coverage for the matching sequence, and iv) matching sequence published in 
a peer reviewed journal article or submitted by the ATCC.  For identification to 
the genus level, all of the above criteria were used, except that a sequence 
identity of ≥ 97.0% was used and 1.0% separation from the next species was 
not required.  NCBI and the doctor fungus website 
(http://www.doctorfungus.org) were used to determine whether various yeast 
names were anamorphs, teleomorphs, or synonyms.  Additionally, as different 
naming schemes exist for various yeast species, we used the following rules 
to remain consistent among the three identification methods:  i) isolates of C. 
albicans and C. africana were always called C. albicans, ii) isolates of C. 
parapsilosis, C. orthopsilosis, and C. metapsilosis were all called C. 
parapsilosis group, and iii) all variants of Cryptococcus neoformans were 
called C. neoformans.   
Creation of the phylogenetic tree.  A representative sequence from each 
species or isolate, in the cases where species-level identification was not 
reached, was aligned using CLUSTAL W2 for multiple alignment with the 
default settings (23) (http://www.ebi.ac.uk/Tools/clustalw2).  The multiple 
alignment file was then used to create a neighbor-joining phylogram with 
CLUSTAL W2.  The C. lusitaniae sequence was excluded from the tree, since 
the sequence was obtained using the reverse primer and therefore would not 
align properly with the other sequences. 
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 RESULTS 
Sequence analysis of the D1/D2 region provides better identification of 
veterinary yeast isolates than either substrate assimilation or fatty acid 
profile analysis.  In this study, we included 109 yeasts isolated during a one 
year period in the Cornell University College of Veterinary Medicine Animal 
Health Diagnostic Center, and representing 91% of the yeasts isolated from 
clinical cases submitted to the laboratory for that year.  Yeast isolates were 
obtained from a variety of animals and sources with representatives from 
mammals, reptiles, amphibians, and avians (Table 4.1).   
 
 
 
Table 1.  Animals included in study and most common yeast species isolated 
from each animal group 
 
 
Animals (n) 
 
No. of different yeast 
species isolated 
 
Most common yeast species 
isolated (% of total) 
 
Avians (10) 
 
7 
 
Candida albicans (40%) 
 
Amphibians (1) 
 
1 
 
Debaryomyces nepalensis (100%) 
 
Mammals (84): 
  
    
      Bovines (8) 
 
4 
 
Candida glabrata (50%) 
    
      Canines (10) 
 
4 
 
Candida albicans (70%) 
    
      Dolphins (8) 
 
3 
 
Arxula adeninivorans (50%) 
    
      Equines (42) 
 
20 
 
Candida parapsilosis group (14%) 
    
      Felines (7) 
 
3 
 
Candida parapsilosis group (57%) 
    
      Other (9) 
 
6 
 
Candida albicans (44%) 
 
Reptiles (14) 
 
11 
 
Candida tropicalis (21%) 
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The class of mammals, which comprised the majority of the isolates (77%), 
was further subdivided into bovines, canines, dolphins, equines, and other 
species, this last group being comprised of animal species represented only 
once in this study.  
 To determine the most effective method of identification for yeasts in 
the veterinary clinical laboratory, we used three methods of identification, 
comparing two commercially available phenotypic methods to sequence 
analysis of the D1/D2 region of the large subunit rRNA gene. The first 
commercial method was a traditional phenotypic method of substrate 
assimilation that determines the ability of the organism to grow in cupules 
containing one of 19 different carbohydrate sources (API 20 C AUX).  Using 
this method, a 7-digit code was generated based upon the presence or 
absence of growth, and the code was then compared to a database provided 
by the manufacturer.  We considered an identification classified by the 
manufacturer as acceptable or better to the species level to be a reliable 
identification.  The second commercial phenotypic method was fatty acid 
profile analysis (Sherlock Microbial Identification System).  This method uses 
GC analysis to determine the fatty acid profile of the yeast.  The software 
provided then compares the profile to a database and provides a similarity 
index, with the confidence in the identification based on the degree of similarity 
to known organisms within the database.  For this method, based on the 
manufacturer’s recommendations, a similarity index of ≥ 0.500 with 0.100 
separation from the next match was considered a good identification.  For 
sequence analysis, we sequenced the D1/D2 region of the large ribosomal 
subunit and used the CLSI recommendations for bacterial sequence analysis 
to assist in interpretation of our results (7).  Thus, for sequence analysis an 
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identification of ≥ 99% sequence similarity with at least 1% separation from the 
next closest species was considered a good identification.  Using these 
methods and interpretive criteria, we found that 52% of the isolates tested 
using substrate assimilation, 47% using fatty acid profile analysis, and 87% 
using D1/D2 sequence analysis could be identified to the species level (Table 
4.2).  These results show that sequence analysis provided the highest percent 
identification to the species level of the three methods. 
 
 
 
 We next examined whether the use of less stringent identification 
criteria would increase the percent identification for any of the methods.  For 
 
Table 2.  Percent Identification of yeast isolates by all methods tested 
 
  
% ID (species level*) 
 
% ID (genus level or lower 
stringency**) 
 
Substrate Assimilation 
 
52 
 
61 
 
Fatty Acid Profile Analysis 
 
47 
 
55 
 
D1/D2 Sequence Analysis 
 
87 
 
98 
 
ITS2 Sequence Analysis 
 
79 
 
90 
 
*Substrate assimilation-acceptable ID or greater to species level, fatty acid profile analysis- 
≥0.500 similarity index with 0.100 separation between species, and sequence analysis- ≥99% 
sequence identity with ≥1% separation between species. 
**Substrate assimilation-acceptable ID or greater to species or genus, fatty acid profile analysis- 
≥0.300 similarity index with 0.100 separation between species, and sequence analysis- ≥97% 
sequence identity without the requirement for 1% separation if the two most similar sequences 
are the same genus. 
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substrate assimilation, we considered identification defined by the 
manufacturer as acceptable to either genus or species level, for fatty acid 
analysis we used a similarity index ≥ 0.300 with 0.100 separation, and for 
sequence analysis we expanded the criteria to include sequence identity of ≥ 
97% without the requirement of ≥ 1% separation if both the most similar and 
the second most similar sequence were of the same genus.  Using these less 
stringent criteria, we found an increase in the number of yeast isolates 
identified by both substrate assimilation and fatty acid analysis, to 61% and 
55% identification, respectively (Table 4.2).  However, for D1/D2 sequence 
analysis we found that we could identify almost all isolates to the genus level 
using this criteria with only two isolates not identified (Table 4.2).  These 
results thus show both that D1/D2 sequence analysis is the better method for 
identification of veterinary yeast isolates to the level of species and that the 
great majority of such isolates can be identified to at least the genus level.   
Comparison of yeast identifications derived from each method tested.  
To further examine the three identification methods, we next compared the 
identification determined by each method.  Since sequence analysis provided 
the identification to species level for the greatest number of these isolates, we 
used sequencing as the reference method and compared the identifications 
determined by the other methods to the sequencing results using isolates that 
had been identified to the species level by D1/D2 sequencing.  For this 
analysis, we used yeasts for which we had identified at least two isolates for 
any given species, a total of 82 isolates.  We found that substrate assimilation 
identified only 50% of the isolates to the species level correctly.  Of members 
of the genus Candida identified in this study, the most common of the genera, 
it identified correctly to the species level 14 of the18 Candida albicans isolates, 
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12 of 13 Candida parapsilosis group isolates, 10 of 12 Candida glabrata 
isolates, and 3 of 9 Candida tropicalis isolates (Fig. 4.1).   
 
 
 
Figure 4.1. Comparison of identifications provided by substrate 
assimilation and fatty acid profile analysis to D1/D2 sequencing results.  
The x-axis and y- axis shows the % of isolates for each species that substrate 
assimilation and fatty acid profile analysis identified concordantly with the 
D1/D2 sequencing results respectively.  The size of the bubbles is proportional 
to the number of yeast isolates for each species and the numbers inside the 
bubbles or next to the bubbles gives the exact number.  Only isolates with a 
good identification to the species level by D1/D2 sequence analysis and where 
n=2 were included in this comparison for a total of 82 isolates. 
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For Trichosporon asahii and Pichia guilliermondii we found that nutrient 
assimilation could identify 1 of 2 isolates correctly for each species.  All of the 
remaining 26 isolates identified by sequencing failed to be identified correctly 
by the nutrient assimilation method.  These species ranged in prevalence from 
eight isolates (10%) for Arxula adeninivorans to two isolates for each of 
Candida thermophila, Cryptococcus neoformans, Pichia mexicana, and Pichia 
rhodanensis species (Fig. 4.1).  In comparison to DNA sequencing, fatty acid 
profile analysis identified 33% of the isolates correctly to the species level (Fig. 
4.1).  Only one species, Candida catenulata, was correctly identified in all 
cases, with both of two isolates being identified (Fig. 4.1).  However, for all 
other species, none was correctly identified more than 50% of the time.  More 
specifically, correct identifications were obtained for 9 of 18 Candida albicans 
isolates, 6 of 13 Candida parapsilosis group isolates, 5 of 12 Candida glabrata 
isolates, 4 of 9 Candida tropicalis isolates, and 1 of 2 Pichia guilliermondii 
isolates (Fig. 4.1).  The rest of the isolates, 26 of 82, were not identified 
correctly. These results thus suggest that, although phenotypic methods may 
provide a species identification, such identifications may frequently be 
incorrect, as we found that 50% of those defined by nutrient assimilation and 
67% by fatty acid analysis failed to agree with that determined by sequencing. 
Sequence analysis of the ITS2 region of yeast isolates.  As we found that 
the identity of 13% of the yeast isolates could not be determined to the species 
level by sequence analysis of the D1/D2 region, we next examined whether 
sequence analysis using the ITS2 region would be useful for further 
identification of these isolates.  We used a subset of the isolates described in 
this study, with 90 yeast isolates being selected, including the 14 isolates not 
previously identified to the species level by sequencing of the D1/D2 region.  
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The entire ITS region was amplified and the ITS2 region was sequenced.  
Using the same criteria for identification as previously described for D1/D2 
analysis, we found that sequence analysis of the ITS2 region could identify 
79% of the 90 yeast isolates analyzed to the species level and 90% to the 
genus level (Table 4.2).  We also found that sequence analysis of the ITS2 
region could further identify 5 of the 14 yeast not previously identified by 
D1/D2 analysis to the species level.  Upon comparison, we found that the two 
methods showed agreement on the identification of isolates 91% of the time.  
In addition, the 9% that did not agree consisted of only two species:  
Geotrichum silvicola and Debaryomyces nepalensis identified by analysis of 
the D1/D2 region were identified respectively as Galactomyces geotrichum 
and Debaryomyces hansenii using the ITS2 region.  For the Geotrichum 
isolates, one explanation for the disagreement may be that at the time of 
analysis there were no ITS2 sequences available for Geotrichum silvicola, 
suggesting that the D1/D2 identification may be the correct one.  For the 
Debaryomyces isolates, the disagreement in identification may occur because 
these species are very closely related, and previous work has shown that it is 
difficult to differentiate between the two with either the D1/D2 or the ITS region 
(27). 
The diversity of yeast in a veterinary population.  In this study, we also 
sought to examine the diversity of yeast observed in a veterinary diagnostic 
laboratory setting.  Using the results from both the D1/D2 and ITS2 sequence 
analysis, we identified 30 different species of yeast among 109 isolates, which 
may underestimate the total, as it does not include the 9 isolates that could not 
be identified to the species level.  These results thus show that there is great 
variety in the yeasts identified from veterinary sources.  In contrast to yeast 
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identified in human hospitals, only 17% of isolates were identified as Candida 
albicans.  Additionally, less than 50% of the total belonged to the species 
Candida albicans, Candida tropicalis, Candida glabrata, and the Candida 
parapsilosis group.  However, one point to note is that 39% of the yeasts were 
isolated from horses, and C. albicans was not isolated from any sample 
obtained from a horse in this study.  In contrast, C. albicans was the 
predominant species identified in avians, canines, and in other mammals 
(Table 4.1).  Additionally, one yeast species that comprised 7% of the total 
yeast isolates was Arxula adeninivorans.  Interestingly, it was isolated only 
from horses and dolphins, and for dolphins it was the predominant species 
identified (Table 4.1).   
 Even with use of sequence analysis of the D1/D2 region and the ITS2 
region, there were still two isolates that could not be identified to the genus 
level using the criteria implemented in this study.  The first (Unknown 1) was 
isolated from a horse and had 96% sequence identity to Candida peoriaensis 
and the second (Unknown 2) was isolated from a reptile and had 83% 
sequence identity to Candida ghanaensis.  These percent identities were both 
based upon D1/D2 sequence analysis; in both cases, the percent identities for 
the ITS2 region were lower and to different organisms.  These results suggest 
in both cases that these two isolates may represent uncharacterized species, 
showing that this method can be used to identify new and unusual yeast 
isolates.  To better understand how these yeasts were related, we examined 
the phylogeny of representative species or isolates (in the cases where 
species identification was not made) identified in this study using sequences 
derived from the D1/D2 region.  As seen in Figure 4.2, Unknown 1 falls into a 
group that contains various Ogataea sp., Pichia sp., and Candida sp.;  
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Figure 4.2. Phylogenetic tree of yeast isolates.  A neighbor-joining 
phylogram of representative D1/D2 sequences was created using Clustal W2 
multiple alignment tool. 
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interestingly all of the isolates in this particular grouping, including Unknown 1, 
came from equine sources.  Unknown 2 falls in a group with Geotrichum 
silvicola, but the length of the branch indicates a distant relationship, 
consistent with the low percent identity to any known D1/D2 sequence (Fig. 
4.2).  These results therefore provide a phylogenetic framework that may be 
useful to the clinician when an exact identification is not possible.  
 
DISCUSSION 
In this study, we examined the usefulness of sequence analysis in 
comparison to more traditional phenotypic methods for identification of 
veterinary yeast isolates and found that sequence analysis provided more 
effective identification of the yeast isolates than either of the phenotypic 
methods tested.  Substrate assimilation identified only 52% of the isolates to 
the species level and 61% to the genus level.  These results are not 
completely surprising since there are reports in the literature of 59.6% - 99.3% 
identification for the API 20 C (11, 36, 42).   For fatty acid profile analysis, we 
could identify 47% of the isolates to the species level and 55% using lower 
stringency for identification.  These results are lower than previously reported, 
however, depending on the growth conditions, previous studies showed 
species level identification of 49%-71% (9, 17, 18).  Thus, our results for the 
phenotypic methods were slightly lower than previously reported, but this may 
be a result of the diversity of veterinary yeast isolates.  Significant to note is 
that the percentage of identifications described above represent all of those 
considered to be acceptable to the species level by each method; they do not 
take into account whether the identification was correct.  Upon comparison of 
these methods to the isolates that had good identifications to the species level 
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by sequence analysis, we found that only 50% and 33% of the identifications 
made by substrate assimilation and fatty acid profile analysis respectively 
were consistent with the identification obtained using sequence analysis.  
These results thus suggest that for veterinary isolates identifications using 
these methods may frequently be incorrect. 
Though sequence analysis of either the D1/D2 region or the ITS2 
region provided higher percent identification than either of the phenotypic 
methods, there were still limitations with each of these methods.  Using 
sequence analysis of the D1/D2 or ITS2 region provided identification of only 
87% and 79% of the isolates to the species level, respectively.  The percent 
identification for both the D1/D2 region and ITS regions are lower than 
previous reports for human clinical isolates (6, 13, 24, 26, 33, 34).  However, 
this may be attributed to the variety of yeast isolated from animal sources, as 
well the number of uncommon isolates found in a veterinary population.  For 
example, in this work we found that Candida albicans accounted for only 17% 
of the isolates and that other common Candida sp. such as Candida tropicalis, 
Candida glabrata, and the Candida parapsilosis group only accounted for 
31%.  Thus, the majority of yeasts isolated from veterinary sources do not 
belong to the species most commonly isolated from human sources (30, 39).  
In fact, one yeast that comprised 7% of the total yeast isolates was Arxula 
adeninivorans, also known as Blastobotrys adeninivorans (21).  It has 
previously been characterized as an anamorphic, nonpathogenic, halotolerant, 
and dimorphic yeast isolated from environmental sources such as soil, maize 
silage, and wood hydrolysates, and has been studied to determine its 
usefulness in biotechnological applications (reviewed by 43).  As mentioned 
above, it is not thought to be a pathogen, though recently a case of 
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Blastobotrys proliferans was reported as  the causative agent of peritonitis in a 
human (35).  However, currently the clinical significance of these isolates is 
not known, but the ability to identify them may allow for future understanding of 
their relevance to veterinary medicine. 
Of the isolates that could not be identified to the species level using 
sequencing of the D1/D2 region, the lack of adequate separation between the 
two most similar species in the database was the most frequent cause. This 
may occur with closely related species, and previous reports suggest that the 
differentiation of closely related species may require sequence analysis of the 
ITS region (10, 38).  However, in our study, we found that sequencing the 
ITS2 region provided identification of only 36% of the isolates not previously 
identified to the species level by D1/D2.  Additionally, for the majority of 
isolates that could not be identified to the species level using the ITS2 region, 
the inability to identify the organism could be attributed to low sequence 
identity to the sequences present in the NCBI database that met the criteria 
described in Materials and Methods.  Therefore, in contrast to the D1/D2 
region, where difficulty in identification was a result of lack of adequate 
separation between the two most similar species, the difficulty with 
identification using the ITS2 region was a result of lack of available ITS2 
sequences in the database for some of the species isolated in this study.  
Thus, based on the current database available, the best identification method 
for veterinary isolates is sequence analysis of the D1/D2 region of the large 
ribosomal subunit. 
Another complication of sequence analysis is that the NCBI database is 
constantly growing and is not highly curated, and as such includes sequences 
that may not be well-supported.  Additionally, naming conventions for yeast 
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are constantly changing.  In addition to the confusion caused by certain yeasts 
having both anamorphic and teleomorphic names, there are also many yeasts 
that have synonymous names.  Furthermore, with the advent of molecular 
phylogenetic analysis there have been several new species suggested as 
subdivisions of traditional species.  For example, a recent study has 
suggested that the species Candida africana may be a separate species from 
C. albicans (41), but there is still uncertainty about this distinction (1, 37).  
Similarly, recent work has shown that Candida parapsilosis groups II and III 
are actually separate species, Candida orthopsilosis and Candida 
metapsilosis, respectively (40), and that Cryptococcus neoformans has been 
described to have variants (25).  These changes in naming conventions 
present significant obstacles to the correct identification of yeast isolates in the 
clinical setting.  As all of the methods tested here rely upon comparisons to 
databases for proper identification, the maintenance of those databases to 
accurately reflect the currently accepted nomenclature is essential.  Therefore, 
as the limitations involved in all methods, including sequencing, are a result of 
database maintenance, one way to address this issue may be to create 
databases of sequences derived from the NCBI collection within individual 
laboratories.   By creating an in-house database, a laboratory might control the 
quality of the sequences and use the sequences of isolates most commonly 
seen in the particular laboratory setting.  In this case, sequences from this 
study could be used to create a database specific for yeast commonly isolated 
from veterinary sources.   
One consideration for the implementation of sequence analysis in the 
clinical laboratory is cost-effectiveness.  Examination of the three methods 
described in this work showed that consumables cost $12 for substrate 
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assimilation using the API 20 C AUX kit, $3 for fatty acid profile analysis, and 
$5-6 for sequence analysis.  However, other important cost considerations 
include a large capital investment in the GC for fatty acid profile analysis, and 
for sequence analysis access to a reliable sequencing center that can provide 
the service at a reasonable cost.  Additional considerations for all three 
methods include the turn-around time for each test.  Using fatty acid analysis 
and sequence analysis a turn-around time of 1-2 days is possible, whereas 
use of substrate assimilation requires 4-5 days.  Therefore, individual 
laboratories must take into account the volume of testing, the need for 
expedience, and the availability of equipment or sequencing services for their 
individual labs to determine the best identification option.  However, based on 
the results presented here and our analysis of costs, we found that sequence 
analysis of the D1/D2 region of the large ribosomal subunit was the most 
accurate and cost-efficient method of yeast identification for this veterinary 
diagnostic laboratory. 
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